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Figure 1-1. Comparison of droplet-based and continuous phase flow microfluidics. (A) Schematic 
of droplet-based flow.9 In droplet plugs, internal convection patterns are observed. This leads to 
rapid mixing and achievement of homogenous conditions across the droplet. Reproduced with 
permission from Wiley and Sons. (B) Droplet generation and flow from converging aqueous dye 
streams. After convergence of streams and segmentation by perfluorodecalin (PFD), color across 
the droplet becomes homogenous after less than 500 µm distance traveled. (C) Convergence of 
dye streams without segmentation. Observed mixing is significantly slower in a continuous flow 
format, with color differences observed well after droplet samples have completely mixed. ........ 3 
Figure 1-2. Assorted unit operations available in droplet microfluidic work. (A) Generation of 
droplets by convergence of flows at a T-junction (top) and flow focusing geometry (bottom).24 The 
volume of achieved droplets can be controlled through both the geometry of the device and fluid 
flow rates (B) Splitting of droplets.25 The ratio achieved between the two flows was controlled by 
changing the length of the narrowed region after the split. (C) Electrophoretic sorting of droplets.26 
Through the application of an electric field, droplets can be polarized and diverted to a secondary 
flow channel. In the absence of a charged electrode, droplets flow exclusively through the primary 
channel (D) Picoinjector for the addition of reagents to individual droplets.27 (E) Coalescence of 
coflowing droplets.28 Reproduced with permission from individual publishers. ........................... 5 
Figure 1-3. Schematics for MALDI-MS 44 (A) and ESI-MS (B) analysis of droplet samples. (A) 
Left - Droplets are flowed off chip into outlet tubing. By use of a moving XY stage, droplets 
emerging from the outlet tubing are deposited onto individual hydrophilic spots. After evaporation 
of carrier phase and sample solvent, matrix solution is spotted onto plate to finalize preparation for 
analysis. Right - Individual droplet spots are exposed to a UV laser, leading to desorption of sample 
and formation of gaseous ions for MS analysis. Reprinted with permission from The American 
Chemical Society (B) To analyze droplets by ESI-MS, trains of sequential droplets are flowed 
through an ESI emitter. Emitters are either composed of conductive material or are coated with 
conductive material to allow for application of ESI voltage directly to spray orifice. As the droplets 
emerge, electrospray is induced, leading to sequential ESI-MS analysis of each individual droplet.
......................................................................................................................................................... 9 
Figure 1-4. (A) Overview of ESI process.51 The application of high voltage to solution flowing 
through emitter leads to electrospray and formation of nebulized droplets, and observation of gas 
phase ions. Reprinted with permission from The American Chemical Society (B) Ion evaporation 
model for small molecule ESI. The nebulized droplets formed by electrospray desolvate to form 
high charge density droplets. Charge repulsion at the surface of the droplets causes ejection of 
lowly solvated ions, which rapidly desolvate to form gas phase ions. (C) General comparison of 
standard (top) and nano (bottom) electrospray emitters. Nanoelectrospray emitters are smaller in 
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size (< 50 µm i.d.), work under nL/min flow conditions, and produced significantly smaller 
nebulized sample droplets. ............................................................................................................ 11 
Figure 1-5. Systems for the ESI-MS analysis of microfluidic droplets. (A) Extraction of droplets 
into aqueous streams for removal of carrier phase before analysis.42 Observed sample band width 
in the stream are dependent on the length of the channel. (B) All-droplet platform for enzyme 
inhibitor screening with ESI-MS analysis of intact droplets.41 Reagents were added to individual 
test compound-containing droplet to run reactions with minimal enzyme and substrate 
consumption. Post-reaction, addition of quenchant was proceeded by analysis of intact sample 
droplets by flowing through an electrospray emitter. Reproduced with permission from individual 
publishers. ..................................................................................................................................... 16 
Figure 1-6. Methods for sampling from spatial arrays with ESI-MS analysis. (A) Withdrawing of 
samples from well plates into segmented flow format has been paired with ESI-MS analysis. 
Through use of syringe pumps and XYZ-sampling devices, the contents of MWPs can be rapidly 
translated into droplet format. This has found use in both expediting ESI-MS analysis, and for 
running in-droplet chemistry39 (B) Sampling directly from a droplet array. By creating droplet 
arrays in an open format, manipulations of nL volume samples can be readily achieved. Sampling 
from each individual droplet directly to ESI-MS analysis is possible through use of specialized 
probes, in which droplet contents merge into a continuous carrier stream, or by direct withdrawal 
of droplet contents.29 Images reprinted with permission from The American Chemical Society 17 
Figure 1-7. Schematic of synaptic cleft during neurotransmission process.109 Neurotransmission 
occurs when one neuron releases neurotransmitters, which move across the synaptic cleft and bind 
to receptors on the adjacent neuron. Neurotransmission is later deactivated through reuptake or 
degradation of neurotransmitters. Sampling probes take up “overflow” neurotransmitters that 
diffuse out of the synaptic cleft and into the extracellular space. Reproduced with permission from 
The National Institute of Health ................................................................................................... 19 
Figure 2-1. Illustration of microfluidic elements that enabled stable analysis of droplets at nL/min 
flow rates. (A) Overview of entire droplet generator and nESI-MS system. From left to right, 
pictured are the syringe pump for driving flow, which leads to the droplet generation chip on a 
microscope for monitoring droplet formation, followed by transfer to nESI-MS analysis. (B) 
Conventional microfluidic droplet generator device setup with 750 µm o.d. inlet and outlet tubing 
interfaced perpendicular to microfluidic channels. (C) Modified droplet generator with insertion 
of 150 µm o.d. inlet and outlet capillaries in-line with microfluidic channels. For (B,C) blue arrows 
indicate inlet lines, while red arrows show outlets. Channels had widths and heights of 100 µm 
and were filled with green food color to aid in visualization. ...................................................... 32 
Figure 2-2. Droplet formation and analysis from original device configuration. Initial attempts at 
making and analyzing droplets in the nL/min flow regime showed inconsistent droplet formation. 
(A) Droplets exported from a device in which vertical punched holes were used as inlets and 
outlets. Irregularities in spacing and droplet size were frequently observed (B) Acetylpyridine mass 
trace (m/z 122→80) for analyzed droplet trains, exhibiting large levels of variability in droplet size 
and spacing.................................................................................................................................... 33 
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Figure 2-3. Several changes to previous configurations were made to stabilize droplet formation 
at nL/min flow rates. (A) Original design involved inserting 750 µm o.d. tubing into vertical 
punched holes, which tended to trap air where indicated by the black circle in the photo. (B) 75 
µm i.d. x 150 µm o.d. capillary was inserted directly in-line with microchannels to avoid issues 
described above. (C) Transfer of droplets to 100 µm i.d. x 165 µm o.d. fused silica capillary 
resulted in adhesion of sample to walls (D) Rain-x® treatment of fused silica allowed for stable 
flow of intact droplets. (E) While improved consistency in droplet formation was observed, 
occasional disruptions were still observed. (F) Lowering inlet capillary i.d. to 20 µm yielded a 
robust droplet formation system. In the shown image, 680 pL droplets were generated at a total 
flow rate of 250 nL/min (4:1 carrier:aqueous). An RSD of 4.2% was observed for the volume of 
30 recorded droplets over 10-minute of droplet generation window. (G,H) PicoclearTM connection 
for transfer of droplets to nESI emitter. (I) 90 pL droplets formed at 20 nL/min with 4:1 carrier 
phase:droplet volume ratio, formed into 40 µm i.d. x 150 µm o.d. capillary. .............................. 34 
Figure 2-4. Generation and analysis of 1.2 nL droplets for over 2.5 h. (A) General scheme of 
microfluidic T-junction for generating droplets. (B) Mass trace for acetylpyridine over the course 
of entire 2.5 h. Samples contained 100 µM acetylpyridine in ivTT solution, diluted 1:1 with 1% 
formic acid. MS-MS analysis of acetylpyridine was performed by monitoring the m/z transition of 
122→80. (C) Excerpt showing steady analysis of distinct droplet samples with no interference 
signal observed due to the carrier phase. ...................................................................................... 35 
Figure 2-5. Effect of fluorosurfactant on nESI-MS. 4 nL droplets with 8 nL fluorous spacing were 
formed from well plates. Both acetylpyridine product and pyridinyl ethylamine substrate were 
present at 1 µm in 100 mM sodium phosphate buffer, which was diluted 1:1 with 1% formic acid 
before droplet generation. (A) Substrate and product traces (top and bottom) for 4 nL droplets 
flowed at 300 nL/min to a 30 µm i.d. spray emitter. Droplet signals were found to be stable, even 
with fluorosurfactant present. (B) Direct comparison of observed droplet MS response for substrate 
and product when analyzed with and without fluorosurfactant present in Novec 7500 carrier phase. 
Droplet response for both analytes was found to only drop by 13% with fluorosurfactant present, 
showing that nESI-MS analysis of droplet samples can be performed with minimal effect from the 
presence of fluorosurfactant. ......................................................................................................... 37 
Figure 2-6. Effect of flow rate on detection of acetylpyridine in biological buffer. 100 µM 
acetylpyridine in 100 mM sodium phosphate was diluted 1:1 with 1% formic acid to make sample 
solution. For measurement of noise, blank solution was prepared as above, with no acetylpyridine 
added. Sample and blank solutions were analyzed by continuous infusion nESI and ESI-MS 
analysis at varying flow rates for 15 and 30 µm i.d. nanoelectrospray emitters. For both sample 
and blank solutions, measured levels were the average of 30 seconds of MS-MS response (500 
data points) after level signal was observed. In both cases, the lowest flow rate was found to be 
best, both in terms of observed signal and S/N. Observed S/N was 392 and 378 at the lowest flow 
rate for 15 and 30 µm i.d. respectively. ........................................................................................ 38 
Figure 2-7. MS-MS analysis of 65 and 300 pL droplets. Samples contained 100 µM acetylpyridine 
(m/z 122→80) in ivTT solution, diluted 1:1 with 1% formic acid. (A) 300 pL droplets at 6 
droplet/s. (B) 65 pL droplets at 4 droplet/s. (C,D) Sample parameters for single population droplet 
experiments and observed analytical stability. ............................................................................. 40 
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Figure 2-8. The effect of changing the scan rate for nESI-MS-MS analysis of a continuous aqueous 
stream containing 100 µM acetylpyridine (A) Lower scan rate (15 ms dwell + 15 ms interscan 
delay) showing high signal stability (B) Higher scan rate (8 ms dwell + 8 ms interscan) showing 
decreased signal stability. Respective RSD’s in signal intensity were 3.1% and 7.8%, lining up 
well with the results listed in figure 2-7C. .................................................................................... 41 
Figure 2-9. Calibration of droplet nESI-MS. (A) Device for controlling analyte concentration of 
formed droplets. (B) Trace for the MS-MS analysis of acetylpyridine (m/z 122→80) during which 
concentration in formed droplets ranged from 20-90 µM. Sample matrix was 1:1 ivTT solution:1% 
formic acid. (C) Plot of MS response against analyte concentration, demonstrating linear response 
(R2 = 0.998). .................................................................................................................................. 43 
Figure 2-10. nESI-MS-MS analysis of pyridinyl ethylamine (m/z 123→80) and acetylpyridine 
(m/z 122→80) in 4 nL droplets generated from a microwell plate. Sample matrix was composed 
of 100 mM sodium phosphate, diluted 1:1 with 1% formic acid. (A) Pyridinyl ethylamine (top) 
and acetylpyridine (bottom) traces for 20x20 units of 1 µM sample and blank droplets (B) 
Normalized average responses for traces observed in 5A,B. S/N values of 19 and 37 were attained 
for acetylpyridine and pyridinyl ethylamine respectively. ........................................................... 45 
Figure 2-11. Formation and analysis of droplet trains containing alternating sample-blank droplets 
to test carry-over. (A) Device design for the formation of alternating droplets. (B) MS-MS trace 
for pyridinyl ethylamine (m/z 123→80) demonstrating nESI-MS-MS analysis with low carry-over 
from sample to blank droplets. Blank droplets were composed of 0.1% formic acid, while samples 
were 0.1% formic acid with 100 µM pyridinyl ethylamine. ......................................................... 46 
Figure 2-12. Evaluation of ATA-117 catalytic activity inside of microfluidic droplets. Samples 
contained 100 mM, pH 7 phosphate buffer and the necessary reaction components, as well as 100 
µM substrate. Negative controls did not have enzyme added. (A) Alternating streams of reaction 
droplets and negative control droplets were converged to create interspersed droplet trains (B) 
Substrate and product MS-MS traces (m/z 123→80 and 122→80 respectively) for interspersed 
droplets after 1 h of incubation. .................................................................................................... 48 
Figure 2-13. Comparison of droplet incubation and analysis against bulk incubation and 
continuous infusion analysis. Normalized responses for substrate and product signal from droplet 
introduction of sample (Figure 2-12b) as well as from incubation in bulk solution are shown. Bulk 
reaction solution (1 mL reaction solution in 2 mL microcentrifuge tube) was introduced directly 
to the nanoelectrospray emitter, without droplet segmentation. Signal was normalized within each 
pairing shown below. Negative reaction took place in absence of ATA-117 enzyme. ................ 49 
Figure 3-1. (A) Overview of probe shape and channel. (B) SEM images of microfabricated push 
pull probe with additional channel for microinjection. The images show i) cross section of the 
probe; ii) top view of an integrated tee (after backside etch to reveal the channels); iii) tip of the 
probe with an estimated sampling area yellow dashed)................................................................ 59 
Figure 3-2. Overview of experimental setup for monitoring brain chemical dynamics with high 
spatiotemporal resolution. (A) Microfabricated push-pull probe with 3 channels. The first and 
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second channels were used for pushing regular aCSF and microinjection of K+-aCSF. The last 
channel was used for pulling sample. The inset showed microfluidic interface between the probe 
and a “fluidic” capillary. This capillary was used for sample transfer prior to connecting with a 
microfabricated cross for simultaneous flow segmentation and reagent addition. (B) Generated 
droplets were collected in a Teflon storage tubing prior to an offline analysis. The inset showed a 
microscopic photograph of the flow segmentation with reagent addition. Food dyes were added to 
sample and reagent for visualization. (C) Photograph of the probe connected to the droplet-based 
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Figure 3-3. In vitro characterization of sampling coupled to segmented flow and reagent addition. 
Samples were a mixture of standards in aCSF and reagents contained fluorescein and a mixture of 
internal standards. (A) Detection of fluroescein in droplets yielded peak heights with RSD of 3% 
(n = 3 device sets). An example of a step change of Gln during switching concentration is shown 
in (B) along with related internal standard added at the same period. (C) Calibration curves from 
ratio of signal traces of standards to internal standards. Linear calibration curves were achieved.
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Figure 3-4. Comparison of signals obtained for MS/MS of 1 µM GABA dissolved in aCSF at (A) 
50 nL/min; (B) 300 nL/min; and (C) 800 nL/min. Each trace shows the signal intensity for the 104 
→ 87 m/z transition for 10 droplets. The first 5 contained GABA and the last 5 were aCSF only. 
For (A) and (B) each droplet was 4 nL and spaced by 4 nL carrier fluid. For (C) each droplet was 
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Figure 3-5. Effect of flow rate on the nESI-MS-MS detection of GABA (A), ACh (B), Gln (C) 
and Glu (D) from aCSF. Left bars in each pairing (blue) represent average signal for analyte 
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Figure 3-7. (A) Formed salt crystal from on nESI emitter after 15 min of aCSF electrospray, 
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 The field of microfluidics has seen notable growth in the past few decades, driven by 
potential advantages in sample processing such as reduced volumes, improved spatial and thermal 
control, and higher throughput than with conventional methods. Droplet microfluidics is a 
variation of microfluidics wherein liquid streams are segmented into discrete “droplet” samples by 
an immiscible carrier phase. This approach augments the benefits of conventional microfluidics 
by also promoting rapid internal mixing and boundaries to restrict molecular movement.
 Combining droplet microfluidics and mass spectrometry (MS) has created enabling 
platforms for studies in drug discovery, biocatalysis, and biochemistry. Described in this 
dissertation are new approaches for paring droplet microfluidics and MS. A system for robust 
nanoelectrospray ionization (nESI)-MS analysis of microfluidic droplets was developed, being the 
first system to demonstrate continuous analysis of 1000’s of droplets. Also achieved was the 
analysis of lower volumes (65 pL) and higher throughputs (10 droplets/s) than previously shown. 
Linear concentration-based responses with < 3% droplet-to-droplet carry-over were achieved, 
showing features crucial for quantitative analysis. Finally, amine transaminase (ATA)-117 
enzymatic activity in droplets was observed, showing capability for applications like drug 
discovery and enzyme evolution. 
 Droplet nESI-MS was then applied to neurochemical monitoring in vivo. Acetylcholine, 
glutamine, glutamate, and gamma aminobutyric acid were all detected from high-saline artificial 
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cerebral spinal fluid (aCSF) sampling matrix in vitro with detection limits applicable for in vivo 
studies. The assay was then paired with a novel in vivo push-pull probe and droplet segmentation 
of sample streams, with < 30 s changes in neurochemical levels observed upon microinjection of 
high potassium aCSF. This overall system for monitoring neurochemical dynamics pushed the 
capabilities for in vivo sampling by combining high spatiotemporal sampling with MS analysis. 
 The droplet nESI-MS method was also applied in the analysis of synthetic reactions as a 
screening approach for robust, high-throughput MS analysis that incorporated highly gentle 
analyte ionization. The reactivity of 17 different drug/drug-like substrates across 3 alkylation 
reactions was examined, showing the ability of nESI-MS to detect a variety of reaction products. 
Throughput as high as three droplets/s was achievable with <10% droplet-to-droplet carry-over. 
Methods for overcoming variable analyte ionization between samples were successfully applied 
to droplet samples. A screen of 72 different conditions for the trifluoromethylation of caffeine was 
performed, with 19F-NMR validation of the top 5 conditions all showing > 20% product yield. 
  Finally, ESI-MS and droplet microfluidics were applied to create a platform for the 
screening of flow reactions. Introduction of 4-7 nL sample droplets to a sheath sprayer allowed 
simultaneous dilution and ESI-MS analysis post-reaction with 10x higher throughput than 
conventional screening systems. Droplet samples were found to be stable for 1 hr under oscillatory 
flow patterns, enabling flow reactions to be performed over extended incubation times without 
observing sample diffusion into carrier streams. Addition of reagents to individual droplets enabled 
performing reactions with each sample only consuming ~3 nL of reagents, which is a marked 
improvement over conventional screening systems that consume µL volumes. 
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 As a whole, the work outlined in this thesis further develops the combination of droplet 
microfluidics and MS. The applications explored herein, namely enzymology, neurochemistry, 
photoredox catalysis, and synthetic flow chemistry not only show the capability of droplet-based 






Microfluidics and Droplet Microfluidics 
 Over the past few decades, the development of microfluidic technologies has been of great 
interest in chemistry, biology, physics and engineering.1–5  Within microfluidic chips, fluids are 
directed through micrometer scale channels. While the desired operations and complexity within 
a microfluidic chip vary with intended application, the benefits of employing microfluidic chips 
are typically founded in the small channel dimensions6. The internal volume necessary to fill 
microfluidic channels is much lower than what would be necessary for macro-scale experiments, 
which can drastically lower sample volume requirements. Rapid transfer of heat from 
microchannels is observed, which can be explained by the high surface area of the channels relative 
to the volume contained within. 
 
 For example, the surface area to volume ratio (
SA
V
) of fluid in a square channel is shown in 
Equation 1-1. Both SA and V are dependent on the length (l) and width (w) of the channel, and the 
SA
V
  is inversely proportional to channel width. Because the 
SA
V
 directly relates to the ability of a 
body to reach thermal equilibrium with its surroundings, the narrow fluid paths associated with 
microfluidic devices enable high levels of thermal control through external heating and cooling 
2 
 
elements. Narrow fluid streams also are conducive to the delivery or uptake of molecules by 
diffusion, as distances to travel are minimal. 
 Microfluidic devices are made from an assortment of materials and methods.7 Original 
approaches followed the lead of the electronics industry, which drove innovation in 
microfabrication techniques for use in making electronic chips. Polydimethylsiloxane (PDMS) is 
a silicone rubber that is the dominant material in the current era of microfluidics. Standard 
workflows start with the formation of a negative master by photolithography. A 
photopolymerizable agent is applied to a flat substrate and rapidly spun to create a film of desired 
depth. This film is then irradiated through a photomask, which selectively allows ultraviolet (UV) 
radiation through in areas where device features are desired. Post-irradiation removal of unexposed 
substrate leads to a master which contains raised features where microfluidic channels will exist. 
A mixture of PDMS monomer and crosslinker is applied to the master and heated to form a PDMS 
sheet with open channels contained on its surface. This sheet can then be bonded to glass, flat 
PDMS, or other feature containing PDMS sheets to create the final device. While PDMS remains 
the most common material in device formation, glass, silicon, thermopolymers, paper, and 
hydrogels all have found extensive use in microfluidics across a variety of applications.7 
 Forces applied to drive flows in microfluidic devices are also diverse.8 Application of 
electric and magnetic fields, capillary action, acoustics, gravity, and centrifugal forces have all 
found use in driving fluid flows in microfluidic devices. Most commonly, flows are driven through 
externally generated pressure gradients. This approach is often achieved through syringe pumps 




Figure 1-1. Comparison of droplet-based and continuous phase flow microfluidics. (A) Schematic of 
droplet-based flow.9 In droplet plugs, internal convection patterns are observed. This leads to rapid mixing 
and achievement of homogenous conditions across the droplet. Reproduced with permission from Wiley 
and Sons. (B) Droplet generation and flow from converging aqueous dye streams. After convergence of 
streams and segmentation by perfluorodecalin (PFD), color across the droplet becomes homogenous after 
less than 500 µm distance traveled. (C) Convergence of dye streams without segmentation. Observed 
mixing is significantly slower in a continuous flow format, with color differences observed well after 
droplet samples have completely mixed. 
 
 One subset of microfluidics that has garnered significant recent interest is droplet 
microfluidics.10–13 In droplet microfluidics, individual droplet samples are formed within 
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microchannels in place of continuous fluid streams. To form these droplets, one or more 
immiscible carrier phase(s) are applied to segment fluid streams and create distinct sample 
boundaries (Figure 1A,B).9 Early examples segmented flows by gases for automating clinical 
diagnostics.14,15 The use of liquid carrier phases has since become favored due to their drastically 
lower compressibility.  Droplet microfluidic approaches present advantages beyond what is 
observed in continuous flow microfluidics.10,16,17 Manipulation of individual droplets, typically 
ranging from fL-µL in volume, can be achieved at extremely high rates, sometimes even into the 
kHz range.18,19 A wide variety of sample manipulations have been demonstrated for droplet 
microfluidic systems (Figure 1-2), yielding systems capable of rapid sample processing. These 
droplets are conducive to work where the systems to study are extremely small, such as in the 
isolation of single cells or in nanoparticle growth.20–23 Owing to internal convection patterns, in-
flow droplets exhibit rapid mixing (Figure 1-1).9 This can lead to significant benefits, including 





Figure 1-2. Assorted unit operations available in droplet microfluidic work. (A) Generation of droplets by 
convergence of flows at a T-junction (top) and flow focusing geometry (bottom).24 The volume of achieved 
droplets can be controlled through both the geometry of the device and fluid flow rates (B) Splitting of 
droplets.25 The ratio achieved between the two flows was controlled by changing the length of the narrowed 
region after the split. (C) Electrophoretic sorting of droplets.26 Through the application of an electric field, 
droplets can be polarized and diverted to a secondary flow channel. In the absence of a charged electrode, 
droplets flow exclusively through the primary channel (D) Picoinjector for the addition of reagents to 
individual droplets.27 (E) Coalescence of coflowing droplets.28 Reproduced with permission from individual 
publishers. 
 
Chemical Analysis in Droplet Microfluidics 
 The chemical analysis of droplet samples presents challenges not typically observed in 
macro-scale studies. Any analytical system employed must be capable of handling very small 
samples, along with being compatible with the presence of carrier phase between droplets. These 
restrictions make the use of many conventional approaches extremely difficult. Most commonly, 
optical detection schemes are employed. Optical microscopy systems are easily paired with 
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microfluidic devices for analyzing droplet samples. Fluorescent detection is especially 
prevalent.29,30 Fluorescence affords sensitive analysis, even with the narrow pathlengths associated 
with microfluidic channels. While powerful optical assays exist for droplet samples, there are 
major drawbacks. Most analytes of interest will not create a usable concentration-based change in 
optical response. Electrochemical detection from droplets has also been employed.31,32 While 
removing the need for optical activity, analytes now need to be electro-active, and carrier phases 
can confound analysis.33 In both optical and electrochemical detection schemes, small molecule 
detection from complex samples continues to be difficult, as development of highly specific assays 
can be laborious and often not practical when measurements of multiple analytes is desired. 
 Analytical chemical separations are often utilized to aid in analyte detection from complex 
samples. By isolating analytes from interfering sample components before detection, separation 
techniques impart enhanced chemical selectivity during analysis. Pairing chemical separations 
with droplet samples is difficult, as most techniques suffer from some combination of being time 
intensive, incompatible with droplet carrier phases, or incompatible with low volume samples. As 
such, examples of separations being applied to droplet samples has been limited in scope, with the 
most success being observed through the use of chip electrophoresis.34–38 
 Mass spectrometry (MS) is a highly versatile analytical technique. By detecting analytes 
based on their mass to charge ratio (m/z), MS presents features desirable for droplet microfluidic 
work. As analytes only need a net charge in order to be detected, MS can detect a wide range of 
analytes without need for optical labelling. This approach to analyte detection imparts high 
selectivity while also directly detecting a wide range of analytes, often allowing MS to monitor 
analytes from complex samples without needing separations or analyte specific assay conditions. 
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MS is also amenable to the rapid analysis of large populations of droplets. Depending on the 
applied conditions and instrumentation, scan rates in the range of 10-1000 scans/s can be achieved, 
giving the ability to analyze multiple droplets/s.39,40 
 Thus far, work combining mass spectrometry and droplet microfluidics has most 
commonly used quadrupole mass analyzers, with time-of-flight mass analyzers also finding 
use.29,39–43 In a quadrupole mass analyzer, four linear metal rods are mounted in a square pattern, 
with ions passing into and through the contained cavity. A combination of direct current (DC) and 
alternating current (AC) voltages are applied to the rods, with opposite rods experience the same 
voltages. By varying the magnitude of the applied voltages, quadrupole mass analyzers act as 
filters for ions passing through them, allowing for only the selected m/z ions to pass through and 
reach the detector. In a triple quadrupole (QqQ) mass spectrometer, gas phase chemistry and two 
mass selection events allow for greater structural determination and selectivity than a single 
quadrupole alone. Mass selection in the first quadrupole is followed by gas phase chemistry, 
typically fragmentation through collisions with an inert gas, in the second quadrupole. Ions that 
emerge from the second quadrupole then can pass through the final quadrupole analyzer and to the 
detector. This type of operation is referred to as tandem MS or MS-MS. 
 To form gas phase ions for MS, some manner of sample ionization must be performed. 
Examples of combining MS and droplet microfluidics have mainly involved either matrix assisted 
laser desorption/ionization (MALDI)44–46, or electrospray ionization (ESI)39,40,42,43,47–50 to create 
gaseous ions from droplet samples (Figure 1-3).44 For work with MALDI, droplets are spotted 
onto a plate and solvent evaporated off, followed by application of ionization matrix. An ultraviolet 
(UV) laser is fired at the individual sample spots. The photons are absorbed by the matrix, which 
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leads to desorption and ionization of sample. This approach does suffer from background 
associated with the matrix, as well as requiring additional sample preparation after depositing the 
droplets. 
 In the ESI process, liquid sample that emerges from an electrospray needle is exposed to a 
high electric potential (~1-5 kV), which, by repulsion of charged species in solution, causes the 
formation of a Taylor cone. Sample then is jetted outward into a nebulized plume, where a series 
of desolvation and splitting events creates a population of highly charged aerosol droplets. The 
mechanism for gaseous ion formation varies based on the size and structure of the molecule. For 
small molecules, ejection from the surface of these charge dense droplets leads to the formation of 
gaseous analyte ions (Figure 1-4).51 ESI provides features that are amenable to droplet microfluidic 
work. As it forms analyte ions from liquid samples, ESI can directly analyze microfluidic droplets. 
The ESI process has been shown to be tolerant to the presence of fluorous carrier phases,52 and 
since Taylor cone formation is fast (< 1 ms)53, ESI is capable of processing multiple droplet 
samples per second. ESI is also a gentle ionization technique, allowing for the observation of labile 





Figure 1-3. Schematics for MALDI-MS 44 (A) and ESI-MS (B) analysis of droplet samples. (A) Left - 
Droplets are flowed off chip into outlet tubing. By use of a moving XY stage, droplets emerging from the 
outlet tubing are deposited onto individual hydrophilic spots. After evaporation of carrier phase and sample 
solvent, matrix solution is spotted onto plate to finalize preparation for analysis. Right - Individual droplet 
spots are exposed to a UV laser, leading to desorption of sample and formation of gaseous ions for MS 
analysis. Reprinted with permission from The American Chemical Society (B) To analyze droplets by ESI-
MS, trains of sequential droplets are flowed through an ESI emitter. Emitters are either composed of 
conductive material or are coated with conductive material to allow for application of ESI voltage directly 
to spray orifice. As the droplets emerge, electrospray is induced, leading to sequential ESI-MS analysis of 
each individual droplet. 
 
 ESI does have shortcomings that limit its applications in microfluidic droplets. A typical 
ESI emitter will have an inner diameter (I.D.) of around 100 µm. A sphere with a 100 µm diameter 
has a volume of 523 pL. This volume represents the lower limit of the size of droplets that could 
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be stably sprayed, as smaller droplets could pack together and have their boundaries become 
indistinguishable on the MS data trace. The process of forming gas phase ions by ESI is also easily 
affected by sample matrices. Biological droplet samples will often contain complex matrices with 
many components in the high µM and mM range. These matrix components can hinder the 
formation of gas phase analytes, an effect termed “ion suppression”, which can occur at multiple 
points during the ESI process.54,55 Analyte ions need to exist near the surface of the nebulized 
droplets. There is limited surface area for charged molecules to exist, so high concentration 
inorganic ions, like Na+ and Cl-, and molecules exhibiting high surface activity can cause 
suppression by outcompeting analytes of interest for this surface space. Competition for charge is 
also an issue. For example, positive ion formation by adduction of H+ can be hindered in the 
presence of basic molecules, like phosphate or Tris buffers used in biological studies. This 
competition can exist in both the liquid and gas phase. Other effects, like ion pairing and 
coprecipitation with matrix components can also contribute to ion suppression. The end effect of 
any of these processes is that fewer gas phase analyte ions enter the mass spectrometer, resulting 
in reduced response and increased detection limits. 
 NanoESI (nESI) is a nL/min flow variation on standard ESI which offers the potential to 
overcome these shortcomings. The emitters employed are significantly smaller than in standard 
ESI, which can accommodate smaller volume droplets. Also, the nebulized droplets formed from 
nanoelectrospray emitters are significantly smaller in size and have increased surface area to 
volume ratios relative to droplets formed by standard electrospray emitters. As such, these smaller 
droplets observe higher rates of evaporation relative to the contained volume, as well as increased 
surface area per analyte, leading to increases in ionization efficiency.56,57 These increases are 
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especially important for the observation of suppressed species, and improvements in sensitivity 
can be observed. The use of nESI-MS has can enable the analysis of complex samples with 
minimal sample cleanup. Direct detection of small molecules from biological samples such as 
cellular media, human blood spots, and urine have be accomplished by nESI-MS.58–60 As such, 
nESI-MS present a powerful tool in the development of droplet-based analytical systems.  
 
Figure 1-4. (A) Overview of ESI process.51 The application of high voltage to solution flowing through 
emitter leads to electrospray and formation of nebulized droplets, and observation of gas phase ions. 
Reprinted with permission from The American Chemical Society (B) Ion evaporation model for small 
molecule ESI. The nebulized droplets formed by electrospray desolvate to form high charge density 
droplets. Charge repulsion at the surface of the droplets causes ejection of lowly solvated ions, which 
rapidly desolvate to form gas phase ions. (C) General comparison of standard (top) and nano (bottom) 
electrospray emitters. Nanoelectrospray emitters are smaller in size (< 50 µm i.d.), work under nL/min flow 




 The continued advancement of ESI-MS and nESI-MS platforms for analyzing droplet 
samples promises to open new avenues in droplet microfluidic work. Within this thesis, two 
general directions are explored. The first is towards the development of new approaches for the 
high-throughput screening of chemical reactions. The second is for the sensitive detection of small 
molecules from biological samples, specifically for monitoring neurochemicals from in vivo 
sampling with high temporal resolution. 
 
High-Throughput Screening 
 High-throughput screening (HTS) has become a widely applied approach to 
experimentation in pharmaceutical research and beyond.61–63 In a typical HTS workflow, samples 
are arrayed out in either a 96, 384, or 1536 multiwell plate (MWP). Simultaneous reactions are 
performed, and reaction progress is analyzed, typically by use of fluorescence plate readers. By 
employing rapid sample preparation techniques, parallel reactions, and expedited chemical 
analysis, systems capable of processing 104-106 of samples in a single day have become routine. 
Such workflows allow for the collection of massive amounts of information in a short period of 
time, helping to guide future rounds of experimentation or even directly providing conditions for 
practical use. 
 HTS workflows have found utility in diverse applications. The most prevalent is in drug 
development.61,64,65 The process for creation, testing, and approval of a new drug is costly, both 
from the perspective of time and monetary investment. At the beginning of this process is the 
discovery of promising new leads against a target of interest, such as enzymes or cellular receptors. 
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HTS has revolutionized the process of drug discovery. In place of more focused approaches in 
choosing which compounds to test, pharmaceutical companies have developed highly diverse, 
massive compound libraries, some spanning over 1 million compounds. Two approaches to testing 
drug leads are the most dominant. The first is to observe changes in target activity in the presence 
of potential drug molecules. When a compound creates a significant change in the observed 
activity of the target, it is deemed a “hit”. Once identified, hits can be subjected to downstream 
validation and optimization. The other major approach is the use of fragment screens.66–68 In place 
of monitoring target activities, assays are performed that determine which structures show high 
binding affinities. These structures are then used as scaffolds around which new drug molecules 
are designed. 
 Another major area for HTS is in the exploration of synthetic reactions.69–75 The 
motivations for this work are generally split in two directions. The first is in the development of 
novel reactions or the improvement of current processes. The exploration reaction parameters for 
a transformation of interest, including but not limited to catalyst, base/acid, and solvent choices, 
can be achieved both rapidly and at low material cost by HTS methodologies. Conditions that 
promote product formation can then translated to commercially viable scales by process chemists. 
Another screening application would be for the rapid diversification of potential drug compounds. 
Late-stage functionalization of drug compounds has become an important part of the drug 
development process. Methods for screening late-stage functionalization reactions have been of 
recent interest, as they can facilitate the discovery of more effective drugs by promoting access to 
a wider variety of compounds to test. 
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 Similar to work in droplet microfluidics, the use of optical detection has apparent 
limitations. Because the majority of targeted reactions do not naturally create usable optical 
responses, i.e. increased fluorescent active is observed with product formation, assays have to be 
designed with redesigned substrates or with secondary reactions that create responses when 
product formation is observed. The formation of functioning optical assays often requires 
significant resource investment, and such assays are prone to false results. An infamous example 
involves the fluorometric assay Fluor de Lys, which is used to monitor the activity of histone 
deacetylase proteins. Through use of this assay, observed activity of the SIRT1 enzyme was 
drastically increased in the presence of resveratrol and its derivatives.76 These findings played a 
major part in the $725,000,000 acquisition of Sirtris Pharmaceuticals by GlaxoSmithKline. It was 
later found that this increase in activity was not translatable to native SIRT1 substrate and was 
only observed with the fluorescently tagged substrate used in the Fluor de Lys assay.77,78  
 MS has received attention in HTS as a label-free analysis system. A major challenge is 
creating systems that can introduce samples to MS analysis at rates high enough for HTS work. 
Liquid chromatography (LC) and solid phase extraction (SPE) systems are commonly paired with 
ESI-MS analysis. They both have found use in screening applications, but at limited 
throughputs.79–82 The Agilent RapidFire SPE system represents the best throughput of such 
approaches and can achieve throughput as high as 12 samples/min for SPE-ESI-MS analysis, 
though high solvent consumption is required.81–83 It also can operate as a system for rapid flow-
injection ESI-MS.  Achievable throughput upwards of 24 samples/min has been observed, but 
further improvements are limited by conventional autosampling technology and Taylor diffusion 
in carrier streams.83 Droplet segmentation has been shown as one of the most rapid ways to 
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introduce samples from MWPs to ESI-MS analysis.39,41,43,49 By isolating samples with immiscible 
carrier phase in place of miscible carrier streams, droplet segmentation eliminates issues associated 
with Taylor diffusion and widening sample bands. Rapid translation of MWPs into droplet samples 
is achievable through withdrawal of samples into perfluoroalkoxyalkane (PFA) tubing and 
multiplexing droplet formation.39 Once in place, the samples can then be transferred to ESI-MS 
analysis.  
 Several methods for performing ESI on droplet samples have been demonstrated. Droplet 
contents can extracted into a second miscible stream (Figure 1-5A), in an attempt to remove 
potential disturbances in the ESI process due to the presence of immiscible carrier phase.29,42,50,84 
These devices function similarly to conventional flow-injection systems and contain the same 
restrictions in achievable throughput. Once droplets merge into a continuous miscible stream, they 
no longer are constrained by an immiscible carrier phase. Molecular diffusion can lead to unwanted 
dilution and overlap of sample bands at high throughputs. The ESI-MS analysis of intact droplet 
trains is also achievable (Figure 1-5B,1-6B). It has been shown that stable analysis is possible even 
without removing the carrier phase.39,41,43,47,48 As droplets remain intact up to the point of analysis, 
this approach possibly has the highest achievable throughputs. In the analysis of intact droplets, 
throughput as high as 5 droplets/s have been shown, with promise of further future increases. 
Droplet-based ESI-MS has been implemented in a wide range of studies, with systems applied for 
drug discovery, directed enzyme evolution, protein detection, chemical synthesis, neurochemistry, 




Figure 1-5. Systems for the ESI-MS analysis of microfluidic droplets. (A) Extraction of droplets into 
aqueous streams for removal of carrier phase before analysis.42 Observed sample band width in the stream 
are dependent on the length of the channel. (B) All-droplet platform for enzyme inhibitor screening with 
ESI-MS analysis of intact droplets.41 Reagents were added to individual test compound-containing droplet 
to run reactions with minimal enzyme and substrate consumption. Post-reaction, addition of quenchant was 
proceeded by analysis of intact sample droplets by flowing through an electrospray emitter. Reproduced 
with permission from individual publishers. 
 
 Droplets also present potential utility as microreactors. In a HTS scenario, each droplet is 
analogous to a well on a plate. Within each droplet is a unique reaction of interest leading to HTS 
where volume requirements are decreased by several orders of magnitude. This reduction amounts 
to substantial material conservation when thousands or even millions of samples are under 
consideration. In applications where materials are expensive or not readily available, droplet-based 
systems can enable large scale screens.88–91 For screening purposes, droplet manipulations are 
typically accomplished inside of a closed microfluidic device.92–94 This format promotes extremely 
high throughput and minimal sample consumption but does limit access to individual samples. 
Open microfluidic formats like digital microfluidics and droplet arrays combine some of the 
aspects of closed channel droplet microfluidics and conventional screening platforms.84,95–98 
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Handling throughputs suffer, but sample volumes are still lower than conventional screens, and 
samples are openly accessible, allowing for easy withdrawal for analysis purposes. 
 
Figure 1-6. Methods for sampling from spatial arrays with ESI-MS analysis. (A) Withdrawing of samples 
from well plates into segmented flow format has been paired with ESI-MS analysis. Through use of syringe 
pumps and XYZ-sampling devices, the contents of MWPs can be rapidly translated into droplet format. 
This has found use in both expediting ESI-MS analysis, and for running in-droplet chemistry39 (B) Sampling 
directly from a droplet array. By creating droplet arrays in an open format, manipulations of nL volume 
samples can be readily achieved. Sampling from each individual droplet directly to ESI-MS analysis is 
possible through use of specialized probes, in which droplet contents merge into a continuous carrier stream, 
or by direct withdrawal of droplet contents.29 Images reprinted with permission from The American 
Chemical Society 
 
In Vivo Neurochemical Monitoring 
 Another area where we aimed to apply droplet microfluidics was the study of brain 
chemistry. While considerable efforts have been placed into studying the human brain, we still are 
left with many questions about how it functions. Of particular interest is in the study of 
neurotransmission, or the process by which neurons signal information. Neurotransmitters are a 
broad class of chemicals that enable neurotransmission. Dysregulation of  neurotransmitter levels 
18 
 
has been implicated in a variety of disease states, notably Parkinson’s Disease and Alzheimer’s 
Disease.99–102 Understanding the changes associated with brain chemistry through aging or disease 
states presents possibly the best guide towards improving health-care practices. 
 To provide insight into dynamic changes in living brain tissue, in vivo neurochemical 
monitoring methods are employed. An in vivo neurochemical monitoring method can be appraised 
by different parameters, including invasiveness, achievable temporal and spatial resolutions, 
sensitivity, and chemical coverage.  Electrochemical probes operate by using methods such as 
amperometry and fast scan cyclic voltammetry to monitor redox processes of electroactive 
compounds can at probe’s surface.103–105 These probes provide incredible spatial and temporal 
resolution, even enabling the observation of ms level events. The drawbacks to electrochemical 
probes are that they are prone to fouling with extended use, and to achieve selective detection, are 
often limited to measurements of a single analyte. Imaging methods like positron emission 
tomography monitor electromagnetic radiation without requiring surgical implantation of 




Figure 1-7. Schematic of synaptic cleft during neurotransmission process.109 Neurotransmission occurs 
when one neuron releases neurotransmitters, which move across the synaptic cleft and bind to receptors on 
the adjacent neuron. Neurotransmission is later deactivated through reuptake or degradation of 
neurotransmitters. Sampling probes take up “overflow” neurotransmitters that diffuse out of the synaptic 
cleft and into the extracellular space. Reproduced with permission from The National Institute of Health 
 
 Another approach for in vivo neurochemical monitoring is the use of sampling methods. In 
sampling experiments, molecules from brain tissue diffuse into a sample stream and are exported 
to analysis. While not necessarily inherent to the basic operation of sampling devices, measured 
temporal responses are often poor. Limitations in temporal resolution are typically due to the 
analytical scheme paired with the in vivo sampling. Most commonly employed analytical schemes 
require > 1 µL of sample, which can amount to minutes of sample collection. In order to maintain 
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high temporal responses, analysis of samples in the nL volume range needs to be achieved. 
Microfluidic approaches to sample analysis have been the most prominent in increasing temporal 
resolution of sampling-based methods.110 Especially promising has been the implementation of 
droplet segmentation. Segmenting in vivo sampling streams and pairing with either microchip 
electrophoresis and fluorescent detection or ESI-MS has led to the development of systems capable 
of temporal resolution of 2 s, though the need for chemical derivatization36 and presence of poor 
electrospray matrix48 place significant limitations on the scope of analytes observable by these 
approaches, leaving substantial room for improvement in the analysis of neurochemicals from 
droplet samples. 
 Microdialysis probes find a great deal of use of in vivo sampling work. In a microdialysis 
probe, saline fluid is perfused through a sampling area, which is surrounded by a semi-permeable 
membrane. Small molecules from the nearby brain tissue diffuse through the membrane and into 
the sampling stream for off-site analysis. Microdialysis probes are highly favored for their 
simplicity and robust function, but at 100-400 µm wide, are limited in achievable spatial 
resolution.111,112  Push-pull probes are also applied for in vivo sampling.113,114 In a basic push-pull 
probe, two channels running through the probe have openings in close proximity. The “push” 
channel delivers saline sampling solution directly to the tissue. Neurochemicals diffuse directly 
from the tissue into the sampling fluid, which is continuously being drawn back into the “pull” 
channel. By combining with microfabrication techniques, push-pull probes with sampling areas of 
< 10,000 µm2 have been fabricated, pushing the limits on achievable spatial resolution by in vivo 
sampling.115 The pairing of droplet microfluidics with microfabricated probes presents the 




 Pairing droplet microfluidics with MS analysis promises to deliver powerful analytical 
systems with both rapid throughput and high chemical coverage. This dissertation describes efforts 
to further develop ESI-MS and nESI-MS methods for analyzing droplet samples. The work thus 
far has shown impressive results, though still has considerable room for growth. 
 Chapter 2 describes the development of a platform for interfacing droplet microfluidic 
devices with nESI-MS analysis that addresses the shortcomings of previously developed systems. 
Setup of microfluidic devices to provide stable flows down to 10 nL/min allowed for consistent 
generation and analysis of droplets as small as 65 pL, which were over 3x smaller than previously 
generated. The platform was capable of the robust analysis of over 20,000 consecutive samples, 
which could allow for studies in which large populations are under consideration. Systems to test 
the quantitative abilities of droplet-based nESI-MS analysis were employed, and important aspects 
such as linear concentration-based response and low droplet to droplet carry-over were achieved. 
Finally, the ability to observe in-droplet chemistries was demonstrated through the observed 
conversion of substrate to product for the amine transaminase-117 enzyme. 
 Chapter 3 outlines the creation of a novel sampling/analysis system for in-vivo 
neurochemical monitoring. Conventional approaches to sampling provide poor spatial and 
temporal resolution in the measured neurochemical levels. The use of a microfabricated push-pull 
probe, in combination with droplet segmentation, created a system that achieved unprecedented 
spatiotemporal resolution in an in vivo sampling capacity. Through the application of nESI-MS 
and the addition of isotopically-labelled internal standards to each droplet, quantitative measure of 
3 neurotransmitters, acetylcholine, glutamate, and gamma aminobutyric acid, along with the amino 
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acid glutamine was achieved even from high saline sampling matrix, with detection limits relevant 
to in vivo work. The overall sampling and analysis system was applied to in vivo neurochemical 
monitoring for observation of neurochemical dynamics in rat striatum tissue. Stable analysis of in 
vivo sampling samples was consistently performed for times extending past 1 hour. To show ability 
in monitoring dynamic changes, high K+ stimulation of tissue was performed, with expected 
changes observed in monitored neurochemical levels. 
 Chapter 4 shows the formation screening photoredox catalysis reactions by nESI-MS. 
Simultaneous, uniform irradiation of light-mediated photoredox catalysis reactions was realized 
by placing reaction mixtures in 384 MWPs and irradiating through an array of blue LED lights. 
Post-reaction, samples were diluted and reformatted into 6-8 nL droplets. Flowing samples at 600-
800 nL/min to nESI-MS analysis yielded a system capable of performing triplicate analysis of 
synthetic reactions every 5 seconds, improving the throughput of MS-based systems for screening 
synthetic reactions from MWPs. The application of this system led to the discovery of novel 
reactions in the fluoroalkylation of drug and drug-like molecules. Approaches for screening 
reaction progress through use of standard addition, internal standards, and increased dilution factor 
were also developed, which allowed for changes in analyte ionization across different samples to 
be accounted for. Finally, approaches to improving possible system throughput were explored, 
reaching an analysis rate of 2.9 droplets/s. 
 Chapter 5 examines how droplet microfluidics and ESI-MS analysis can be combined to 
screen in-droplet synthetic reactions and also for screening in-flow reactions. The use of droplet 
microfluidics improved the MS-based screening of flow reactions in terms of sample throughput 
and reagent consumption, as well as by allowing for longer incubation periods to be achieved. An 
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interface with a sheath sprayer allowed for the dilution of droplet samples during the ESI process. 
Analysis of in-droplet photoredox catalysis reactions showed that not only could our method 
monitor in-droplet chemistry, but that in-droplet reactions proceeded at accelerated rates in 
comparison to standard screening scale. An approach based on oscillating flow patterns was used 
to run droplet-based flow reactions for extended incubation periods. Finally, reagent addition to 
acetonitrile droplets was explored. This led to the creation of an all-droplet reactor, where substrate 
containing droplets could have reaction components added, flowed through an 
irradiation/incubation chamber, and analyzed by ESI-MS in one continuous system. 
 Chapter 6 discusses potential future directions for the described droplet-based ESI-MS and 
nESI-MS platforms. Currently unexplored applications for droplet nESI-MS are discussed, with a 
focus placed on protein engineering. Approaches for improving the nESI-MS monitoring of 
neurochemicals is discussed, along with the design of a system for combining microdialysis 
sampling and nESI-MS analysis. A general scheme for the continuous generation and infusing 
droplets off of MWPs is described. Finally, the possibility of the construction of an inclusive 
droplet flow reaction screening device is examined. 
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 High-Throughput Nanoelectrospray Ionization-Mass Spectrometry Analysis of 
Microfluidic Droplet Samples 




 Microfluidic devices have found widespread utility in medicine, chemistry, and biology.1–
3 Droplet microfluidics is a subset of microfluidics in which femtoliter to microliter samples are 
encapsulated by an immiscible carrier phase. Such multi-phase systems enable high-throughput 
manipulation of many discrete samples. Work utilizing droplet microfluidics exhibits multiple 
advantages over macro scale studies, including enhanced heat transfer, rapid mixing, and minimal 
sample consumption.16,17 With these features, droplet microfluidics has found value in many areas 
including screening, synthesis, protein engineering, and bioassays.10,116 
 Although impressive strides have been made in engineering droplet microfluidic devices, 
implementation of methods for monitoring the chemical content of droplet samples has lagged. 
Optical detection schemes are the most commonly employed due to their ease in coupling to 
microfluidic devices.10,33 A downside to optical detection is that analytes often require labelling or 
secondary reactions to give sufficient optical responses. An alternative to optical detection that has 
garnered interest in droplet microfluidics is mass spectrometry (MS), as it can detect a wide variety 
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of analytes without the need for labels or innate optical activity.10,33 MS analysis also offers the 
potential for a high amount of qualitative and quantitative information, even for complex mixtures. 
Successful pairing of electrospray ionization-MS (ESI-MS) with nanoliter volume droplet 
samples has facilitated high-throughput MS studies in areas such as biocatalysis, organic synthesis, 
and neurochemistry.29,39,43,48,49,86 Unfortunately, ESI-MS is limited in its applicability to droplet 
microfluidics. Its intolerance to biological matrices often necessitates sample cleanup before 
analysis54,55, while large (~100 µm inner diameter, i.d.) emitter geometries are incompatible with 
picoliter volume droplets29,39,43,48,49,86 (e.g., the diameter of a 65 pL sphere is only 50 µm). 
NanoESI-MS (nESI-MS) is a low flow variation on conventional ESI-MS that uses nL/min 
flow rates and smaller (1-50 µm i.d.) emitters.117 In comparison to conventional ESI-MS analysis, 
nESI-MS presents improved ionization efficiency and matrix tolerance.56,57  Because of these 
improvements, nESI-MS can be used for direct analysis of complex mixtures58–60; however, 
throughput of such measurements is low. For example, some reported high-throughput nESI-MS 
systems use sample loading into preset arrays of nESI emitters, with demonstrated sample 
introduction rate upwards of ~2 samples/min.118–120 Combining rapid droplet microfluidic sample 
manipulations with nESI-MS not only presents an excellent opportunity to improve MS analysis 
of droplet samples; but, also to create higher throughput systems for performing nESI-MS. A few 
examples of nESI-MS applied to analysis of droplets have been reported40–42,84,85,121,122; however, 
no droplet nESI-MS system has exhibited the capacity to process thousands of biological samples 
with high throughput and stability needed for many applications. 
In this report, we describe a system for the robust analysis of microfluidic droplets by nESI-
MS. By establishing flow control down into the nL/min flow range, using commercially available 
nESI emitters, and optimizing nESI source voltages and gas flow, improvements were made to 
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signal stability, throughput, and minimum analyzable volume. The developed analytical system 
accomplished the sequential analysis of over 20,000 surfactant-stabilized droplets containing 
complex media, demonstrating stable analysis from biological samples. Finally, an assay for 
monitoring the catalytic activity of amine transaminase-117 (ATA-117), an (R)-selective 
transaminase which has been used for enantioselective amine synthesis,123,124 inside of droplets 
was implemented. The established system shows potential for pairing droplet microfluidics and 




 PURExpress In Vitro Protein Synthesis Kit (New England Biolabs, Ipswitch, MA), 1-
pyridin-3-yl-ethylamine, 1-pyridin-3-yl-ethanone, and transaminase enzyme ATA-117 were all 
provided by Merck & Company. Novec 7500 fluorinated liquid was purchased from Oakwood 
Products (Estill, SC).  008-Fluorosurfactant (poly(ethylene glycol)-di-(krytox-FSH amide) 
fluoropolymer), was purchased from RAN Biotechnologies (Beverly, MA). All other reagents 
were purchased from Fisher Scientific or Sigma Aldrich. 
 
Chip Fabrication 
 Microfluidic chips were fabricated using standard soft lithography procedures.125 SU-8 
2050 photoresist was spun to desired depth on silicon wafers (University Wafer, Boston, MA) then 
developed using photolithography to form negative masters. Uncured PDMS (Curbell Plastics, 
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Livonia, MI) was poured on top of clean masters or blank wafers, and allowed to cure for 1 h at 
65 °C. Patterned PDMS was irreversibly bonded to blank PDMS by 1 min of exposure to 
atmospheric plasma followed by baking for 2 h at 65 °C. 
 
Microfluidic and Microwell Plate Droplet Generation 
 Microfluidic chips were operated by infusing fluids from Gastight syringes (Hamilton 
Robotics, Reno, NV). For applications involving constant flows, a Fusion 400 syringe pump 
(Chemyx, Stafford, TX) was used. When independent control of streams was necessary, a Model 
102 dual channel microdialysis pump (CMA Microdialysis, Holliston, MA) was used. 20 µm i.d. 
x 150 µm o.d. (inner diameter x outer diameter) fused silica capillary (Polymicro Technologies, 
Phoenix, AZ) ran from syringes directly into the channels of the chip (Figure 2-1C). Generation 
of droplets was performed by converging aqueous sample streams with fluorous carrier phase 
composed of 2% 008-fluorosurfactant in Novec 7500. Droplets generated on chip were exported 
to fused silica capillary, with 40-100 µm i.d. x 150 µm o.d. based on the volume of the generated 
droplets. All fused silica surfaces for handling of droplets were treated with Rain-x® to prevent 
adhesion of water. Treatment procedure involved drawing Rain-x® through capillary by vacuum 
for 15 s, followed by 15 s of isopropanol, finishing with 30 s of air. Capillaries were used for as 
long as a few days at a time after treatment though typically replaced daily.  Figure specific channel 





















Acetylpyridine 122 → 80 15 35 20 
2-7c,d 
2-8b 









Acetylpyridine 122 → 80 15 35 20 
Pyridinyl 
Ethylamine 
123 → 80 15 35 20 
Table 2-1: Channel dimensions and operation conditions for utilized devices. 
 
 For some experiments, droplets were generated from microwell plates as described in 
previous work.41 Briefly, samples were drawn into 100 µm i.d. x 360 µm o.d. PFA tubing (IDEX 
Health and Science, Oak Harbor, WA) by a PHD 2000 Programmable syringe pump (Harvard 
Apparatus, Holliston, TX). The tubing was moved between fluorous and aqueous layers by use of 
an XYZ-position manipulator to create individual droplet samples. Samples were covered in 
Novec 7500 for the experiment with no fluorosurfactant present. When fluorosurfactant was used, 
the fluorous layer was deposited first, as the fluorous layer tended to displace the aqueous layer at 







 Droplet samples were transferred to nESI emitters via a zero dead-volume PicoclearTM 
union (New Objective, Woburn, MA), (Figure 2-1C). 150 µm o.d. capillaries containing droplet 
samples were sheathed in 150 µm i.d. x 360 µm o.d. PFA tubing to provide proper fit into the 
union. nESI emitters were pulled from 50 µm i.d. x 360 µm o.d. fused silica capillary to an i.d. of 
30 µm (FS360-50-30-CE, New Objective, Woburn, MA), except for in the analysis of 65 pL 
droplets, where the emitter was 15 µm i.d. (FS360-50-15-CE, New Objective, Woburn, MA). 
Electrospray potential of 1.75 kV for 30 µm tips and 1.25 kV for 15 µm tips was applied to a 
platinum coating that connected directly to the spray orifice. Mass spectrometry analysis was 
performed on a Micromass Quattro Ultima triple-quadrupole mass spectrometer (Waters, Milford, 
MA), operating in MS-MS mode. A 150 L/h nitrogen cone gas emerging from sampling inlet was 
found to drastically improve signal stability between droplets, possibly by forcing carrier phase 
away from the emitter aperture. Conditions for MS-MS operation are listed in table 2-2. For data 
analysis, the signal for each droplet was reported as the highest intensity observed across its peak. 
When reported, RSDs for droplet response are calculated from 30 droplets equally spread across 


















2-1a,b T 100 100 100 - - - 
2-4b,c T 50 50 50 1200 170 330 
2-7a,c T 60 40 40 300 110 110 
2-7c T 60 40 40 300 175 175 
2-7c T 60 40 40 300 80 80 
2-13 T 60 40 40 400 150 150 
2-7b,d T 60 20 40 65 8 32 
2-7d T 60 20 40 65 4 16 
2-7d T 60 20 40 65 12 48 
2-2b,c,d,e,f T 50 50 50 700 50 200 
2-9b Dual Stream T 60 40 50 800 75 150 
2-10b Cross 60 50 40 400 200 800 
2-11b Converging T’s 60 40 50 600 75 300 
Table 2-2: MRM conditions of analytes. All analytes were monitored using MS-MS analysis. Interscan 
and interchannel delays were set to be equal to the dwell time. 
 
ATA-117 Transaminase Assay 
 ATA-117 reactions were run in 100 mM sodium phosphate, pH 7 buffer. Enzyme was 
present at a concentration of 0.2 mg/mL. Pyridoxal phosphate cofactor, pyridinyl amine substrate, 
and pyruvic acid substrate were all present at 100 µM. Negative control reactions were made 
without the presence of enzyme. Reactions were run for 1 h at 37 °C before analysis (Reaction 2-
1). 
 




Results and Discussion 
Device Configuration for Stable nL/min Droplet Manipulation 
 Droplets can be pumped into an ESI emitter from microfluidic droplet generators or by 
collecting droplets from a source and then reinjecting them into an emitter.40,85 For convenience 
of testing, we coupled microfluidic droplet generation from a T-junction directly to a nESI emitter 
for most experiments (Figure 2-1A). Successful pairing of nESI-MS to a fluidic system requires 
control of flows in the nL/min range. Initially tested devices for online droplet generation were 
prepared similar to previous reports analyzing pL scale droplets by nESI-MS.40,42 In this approach, 
relatively large inlet tubing (> 0.5 mm o.d.) is inserted into holes punched perpendicular to the 
microchannels in the PDMS device (Figure 2-1B). These devices experienced inconsistent droplet 
formation when operated below 1 µL/min, leading to irregular droplet signal upon analysis (Figure 
2-2). Trapping of air at inlets, shifting of large tubing inside of devices, and inconsistent flow out 
of the inlet lines were all observed as potential causes of flow inconsistency. Each of these potential 
problems were eliminated by changes in the device. Briefly, placing the inlet tube in-line with the 
microfluidic channels and lowering inlet capillary i.d/o.d. helped to stabilize flow rates (Figure 2-
1C).  Direct insertion of 20 µm i.d. x 150 µm o.d. capillary in-line with microchannels eased the 
release of air trapped at the inlets. The narrow tubing was more pliable than thicker tubing, helping 
to reduce shifting inside of devices. Also, smaller bore tubing increased the pressure drop across 
the inlet lines and provided greater flow stability, yielding a system capable of generating droplets 
at nL/min flow rates with high consistency in droplet size and spacing. PicoclearTM zero dead 
volume unions were used to connect outlet capillary to nESI emitters, allowing for reliable transfer 
to nESI-MS analysis. Outlet capillary and nESI emitters were treated with Rain-x®, a commercially 
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available water repellant, to prevent aqueous droplets from sticking to the fused silica surfaces. 
Further representation of the described changes and effect on droplet formation down to below 
100 pL can be found in Figure 2-3. These approaches combined allowed reliable formation and 




Figure 2-1. Illustration of microfluidic elements that enabled stable analysis of droplets at nL/min flow 
rates. (A) Overview of entire droplet generator and nESI-MS system. From left to right, pictured are the 
syringe pump for driving flow, which leads to the droplet generation chip on a microscope for monitoring 
droplet formation, followed by transfer to nESI-MS analysis. (B) Conventional microfluidic droplet 
generator device setup with 750 µm o.d. inlet and outlet tubing interfaced perpendicular to microfluidic 
channels. (C) Modified droplet generator with insertion of 150 µm o.d. inlet and outlet capillaries in-line 
with microfluidic channels. For (B,C) blue arrows indicate inlet lines, while red arrows show outlets. 






Figure 2-2. Droplet formation and analysis from original device configuration. Initial attempts at making 
and analyzing droplets in the nL/min flow regime showed inconsistent droplet formation. (A) Droplets 
exported from a device in which vertical punched holes were used as inlets and outlets. Irregularities in 
spacing and droplet size were frequently observed (B) Acetylpyridine mass trace (m/z 122→80) for 





Figure 2-3. Several changes to previous configurations were made to stabilize droplet formation at 
nL/min flow rates. (A) Original design involved inserting 750 µm o.d. tubing into vertical punched holes, 
which tended to trap air where indicated by the black circle in the photo. (B) 75 µm i.d. x 150 µm o.d. 
capillary was inserted directly in-line with microchannels to avoid issues described above. (C) Transfer of 
droplets to 100 µm i.d. x 165 µm o.d. fused silica capillary resulted in adhesion of sample to walls (D) 
Rain-x® treatment of fused silica allowed for stable flow of intact droplets. (E) While improved 
consistency in droplet formation was observed, occasional disruptions were still observed. (F) Lowering 
inlet capillary i.d. to 20 µm yielded a robust droplet formation system. In the shown image, 680 pL 
droplets were generated at a total flow rate of 250 nL/min (4:1 carrier:aqueous). An RSD of 4.2% was 
observed for the volume of 30 recorded droplets over 10-minute of droplet generation window. (G,H) 
PicoclearTM connection for transfer of droplets to nESI emitter. (I) 90 pL droplets formed at 20 nL/min 
with 4:1 carrier phase:droplet volume ratio, formed into 40 µm i.d. x 150 µm o.d. capillary. 
 
Stable Long-Term Analysis by nESI-MS 
 With the improvement in flow, droplet generation, and transfer to nESI, we began testing 
the system for stability of nESI-MS. The general operation of a T-junction droplet generator, which 
can be used to continuously create droplets, is shown in Figure 2-4A. Figure 2-4B illustrates an 
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example of nESI-MS detection of 1-pyridin-3-yl-ethanone (acetylpyridine), a product of the ATA-
117 transamination reaction, in a long sequence of 1.2 nL droplets formed continuously formed by 
the T-junction at 2.1 droplets/s. Acetylpyridine was dissolved into in vitro protein translation and 
transcription solution (ivTT) to a concentration of 100 µM, and then diluted 1:1 with aqueous 1% 
formic acid before introduction to the microfluidic system. Distinct, stable droplet signals could 
be observed without interference between samples due to the carrier phase (Figure 2-4C), similar 
to previous reports.39,122 Overall flow for the system was 500 nL/min, split 1:2 between droplet 
and carrier phases. Under these conditions, MS analysis of acetylpyridine could be performed for 
at least 2.5 h and 20,000 droplets, with a peak height RSD of 3.7% and no notable drift in signal. 
 
Figure 2-4. Generation and analysis of 1.2 nL droplets for over 2.5 h. (A) General scheme of microfluidic 
T-junction for generating droplets. (B) Mass trace for acetylpyridine over the course of entire 2.5 h. Samples 
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contained 100 µM acetylpyridine in ivTT solution, diluted 1:1 with 1% formic acid. MS-MS analysis of 
acetylpyridine was performed by monitoring the m/z transition of 122→80. (C) Excerpt showing steady 
analysis of distinct droplet samples with no interference signal observed due to the carrier phase. 
 
High analytical stability was observed even in the presence of ivTT, a complex matrix 
containing millimolar levels of inorganic salts and all the necessary components for the 
transcription of RNA and subsequent expression of protein. In addition, analysis could be 
performed from intact droplet samples, even though the fluorous carrier phase contained droplet 
stabilizing fluorosurfactant40 (2% 008-Fluorosurfactant). Comparative studies showed that the 
presence of surfactant reduced signal by only 13% when samples were analyzed at 300 nL/min 
(Figure 2-5). Such surfactants are often, but not always, necessary for droplet manipulations. 
Extensive operation over a few weeks led to buildup of a black substance inside of the MS source 
region and lowered ion transmission. This residue is believed to be due to surfactant as it was not 
observed when working with surfactantless carrier phases.  Observed signal intensities could 
gradually fall as far as 5-10x, but this effect was completely reversible by wiping the source region 
with 50:50 methanol:water and a soft cloth. This requirement for more frequent cleaning can be 






Figure 2-5. Effect of fluorosurfactant on nESI-MS. 4 nL droplets with 8 nL fluorous spacing were formed 
from well plates. Both acetylpyridine product and pyridinyl ethylamine substrate were present at 1 µm in 
100 mM sodium phosphate buffer, which was diluted 1:1 with 1% formic acid before droplet generation. 
(A) Substrate and product traces (top and bottom) for 4 nL droplets flowed at 300 nL/min to a 30 µm i.d. 
spray emitter. Droplet signals were found to be stable, even with fluorosurfactant present. (B) Direct 
comparison of observed droplet MS response for substrate and product when analyzed with and without 
fluorosurfactant present in Novec 7500 carrier phase. Droplet response for both analytes was found to only 
drop by 13% with fluorosurfactant present, showing that nESI-MS analysis of droplet samples can be 






High-Throughput MS Analysis of pL Volume Droplets 
A key feature of the configuration in Figure 2-1 is that it facilitates consistent operation at 
flow rates below 1 µL/min. The ability to work at low flow rates offers significant advantages. 
Increases to matrix tolerance and ionization efficiency can be achieved by lowering flow rates.56,57 
We found this improvement to be true for the ESI-MS detection of acetylpyridine in 100 mM 
phosphate buffer. As shown in Figure 2-6, reducing the flow rate from 1500 to 20 nL/min with 15 
µm i.d. emitters and from 5000 to 160 nL/min for 30 µm i.d. emitters resulted in significant gains 
in S/N ratio. Low flow rates are also compatible with smaller droplets. Droplet microfluidic studies 
often work with samples of < 500 pL. Reducing droplet volume requires proportionately lower 
infusion flow rates to attain similar residence times at the tip of the nanoelectrospray emitter and 
provide comparable time for MS analysis. Therefore, operating at lower flow rates can allow for 
the introduction of smaller samples to nESI emitters with sufficient residence time for MS and 
provide the benefits of nESI while maintaining good throughput.  
 
Figure 2-6. Effect of flow rate on detection of acetylpyridine in biological buffer. 100 µM acetylpyridine 
in 100 mM sodium phosphate was diluted 1:1 with 1% formic acid to make sample solution. For 
measurement of noise, blank solution was prepared as above, with no acetylpyridine added. Sample and 
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blank solutions were analyzed by continuous infusion nESI and ESI-MS analysis at varying flow rates for 
15 and 30 µm i.d. nanoelectrospray emitters. For both sample and blank solutions, measured levels were 
the average of 30 seconds of MS-MS response (500 data points) after level signal was observed. In both 
cases, the lowest flow rate was found to be best, both in terms of observed signal and S/N. Observed S/N 
was 392 and 378 at the lowest flow rate for 15 and 30 µm i.d. respectively. 
 
To explore the ability of our system to function with smaller droplets at lower flow rates, 
T-junctions with smaller cross-sectional areas (listed in Table 2-1) were employed for droplet 
generation with online analysis, using the same sample as in the previous section. Droplet 
throughput was adjusted by changing inlet flow rates. Example traces, as well as system 
performance are displayed in Figure 2-7. Using a 30 µm i.d. nESI emitter tip, it was possible to 
generate stable signal (peak height RSD ranging from 4.0-7.1%) for 300 pL droplets at sample 
throughputs of 4, 6, and 10 droplets/s (Figure 2-7A), corresponding to flow rates as low as 160 
nL/min. Increased droplet-to-droplet signal variability was seen at 10 droplets/s. This instability 
could be attributable to the increased scan rate necessary to observe the individual droplet nESI 
events (Figure 2-8). In principle, further increases to throughput are possible, though a mass 




Figure 2-7. MS-MS analysis of 65 and 300 pL droplets. Samples contained 100 µM acetylpyridine (m/z 
122→80) in ivTT solution, diluted 1:1 with 1% formic acid. (A) 300 pL droplets at 6 droplet/s. (B) 65 pL 






Figure 2-8. The effect of changing the scan rate for nESI-MS-MS analysis of a continuous aqueous stream 
containing 100 µM acetylpyridine (A) Lower scan rate (15 ms dwell + 15 ms interscan delay) showing high 
signal stability (B) Higher scan rate (8 ms dwell + 8 ms interscan) showing decreased signal stability. 
Respective RSD’s in signal intensity were 3.1% and 7.8%, lining up well with the results listed in figure 2-
7C. 
 
 Reducing droplet volumes down to 65 pL, which is approximately 3x smaller than any 
previous reports analyzing intact droplets by ESI-MS or nESI-MS analysis, was also compatible 
with nESI-MS (Figure 2-7B).85  To resolve MS signals for individual 65 pL droplets, it was 
necessary to reduce emitter i.d. to 15 µm from 30 µm i.d., possibly indicating that droplets will 
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not spray properly if they are too small relative to the emitter tip. Spacing to droplet volume ratio 
was increased to 4:1, as the droplets were spherical in the 50 µm emitter capillary and were 
observed to float into proximity of each other when lower spacing was applied.  nESI-MS analysis 
of 65 pL droplets gave a peak height RSD of 4.7% at a throughput of 4 samples/s and 40 nL/min 
flow, and 4.6% for 2 samples/s at 20 nL/min. Work at these very low flow rates could enable 
studies where analyte ionization is poor. These results attest capability both in high throughput 
analysis of droplets down to 65 pL in volume, as well as while applying flow rates well below 1 
µL/min. 
 
Quantitative Analysis of Droplet Samples 
To test the quantitative abilities of the developed system, analysis of droplets of varying 
concentration of acetylpyridine was performed. A chip was designed that merged streams of 
acetylpyridine sample and blank solutions (Figure 2-9A). The concentration of acetylpyridine was 
varied by changing the flow ratio of the two merging streams. Droplets of 800 pL in volume were 
formed at a frequency of 1.5 droplets/s and a droplet to carrier volume ratio of 1:2, giving an 
overall flow rate of 225 nL/min. For the analysis, 30 consecutive droplets were selected from 
regions where signal plateaued (Figure 2-9B). Concentration-based linear response was clearly 
observed from 20-90 µM acetylpyridine (Figure 2-9C), showing the ability of pL droplet nESI-




Figure 2-9. Calibration of droplet nESI-MS. (A) Device for controlling analyte concentration of formed 
droplets. (B) Trace for the MS-MS analysis of acetylpyridine (m/z 122→80) during which concentration 
in formed droplets ranged from 20-90 µM. Sample matrix was 1:1 ivTT solution:1% formic acid. (C) Plot 
of MS response against analyte concentration, demonstrating linear response (R2 = 0.998). 
 
 We also examined the lower limits of concentration measurable by droplet nESI-MS in 
presence of high saline matrix. For these tests, 4 nL droplets were formed from microwell plates 
with 8 nL of Novec 7500 fluorous spacer fluid between each droplet. 1 µM ATA-117 substrate 
and product in 100 mM sodium phosphate buffer, diluted 1:1 with 1% formic acid, was used for 
the sample. Blank solution was prepared with neither analyte present. For both analytes, signal 
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was easily discernible (Figure 2-10A) when flowing to nESI-MS analysis at 300 nL/min.  S/N 
values of 19 and 37 were obtained for product and substrate respectively, giving 3*S/N estimated 
LODs of 160 nM and 80 nM even from high-salt buffer (Figure 2-10B).  Sensitive detection of 
acetylpyridine from ivTT was also observed, though the higher backgrounds associated with this 
complex matrix raised the detection limits. From 65 pL droplets, the LOD was calculated to be 1.5 
µM, which corresponds to the MS detection of only 130 amol of analyte. Better LODs are likely 
possible by lower flow rates or larger droplets that allow longer observation times and newer 




Figure 2-10. nESI-MS-MS analysis of pyridinyl ethylamine (m/z 123→80) and acetylpyridine (m/z 
122→80) in 4 nL droplets generated from a microwell plate. Sample matrix was composed of 100 mM 
sodium phosphate, diluted 1:1 with 1% formic acid. (A) Pyridinyl ethylamine (top) and acetylpyridine 
(bottom) traces for 20x20 units of 1 µM sample and blank droplets (B) Normalized average responses for 
traces observed in 5A,B. S/N values of 19 and 37 were attained for acetylpyridine and pyridinyl ethylamine 
respectively. 
 
Important to performing quantitative measurements of droplet content is the ability to 
analyze consecutive samples with low carry-over. To test carry-over, a microfluidic cross was used 
as shown in Figure 2-11. This device, similar to the sample “chopper” described elsewhere,126 
allowed forming 400 pL droplets alternating between sample and blank where sample contained 
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100 µM 1-pyridin-3-yl-ethylamine (pyridinyl ethylamine), which is the substrate in the ATA-117 
catalyzed reaction. The relative flow rates of carrier fluid:sample:blank were 4:1:1. Sample matrix 
was 0.1% FA. Formed droplets were held 30 min inside of the outlet capillary before analysis, to 
increase the time for potential cross-contamination and carry-over. Samples were then infused to 
the MS at 200 nL/min. Upon analysis, the observed signal intensity of blank droplets was 
approximately 3% of what was observed in the analyte droplets (Figure 2-11B). The low signal in 
the blank droplets indicates that little material, if any, was transferred from droplet-to-droplet as a 
result of the sample handling associated with our developed system, making it compatible with 
work in which individual droplets are unique samples. 
 
Figure 2-11. Formation and analysis of droplet trains containing alternating sample-blank droplets to test 
carry-over. (A) Device design for the formation of alternating droplets. (B) MS-MS trace for pyridinyl 
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ethylamine (m/z 123→80) demonstrating nESI-MS-MS analysis with low carry-over from sample to blank 
droplets. Blank droplets were composed of 0.1% formic acid, while samples were 0.1% formic acid with 
100 µM pyridinyl ethylamine. 
 
Evaluation of In-Droplet Enzyme Activity 
 As a demonstration of the potential value of a high-throughput nESI-MS system, enzyme 
activity within droplets was monitored. Evaluating samples based on the presence or absence of 
active enzyme might be of interest for enzyme engineering43 and drug discovery39,41 among other 
applications. Initial attempts to form droplet trains containing alternating samples of the full ATA-
117 reaction and negative control (no enzyme present) were performed with the device shown in 
Figure 2-11A. It was found that the presence of enzyme in the sample led to sporadic merging of 
the two inlet streams, making it impossible to reliably form the desired droplets. Therefore, we 
used the design in Figure 2-12A, where droplets are formed at two separate locations, followed by 
convergence of the two streams. Mixing of reaction components followed by the setup of the 
microfluidic device took 20 min. Trains of 800 pL droplets, spaced 4:1, were incubated at 37 °C 
for 1 h. Subsequent analysis of the incubated droplets was performed at 160 nL/min infusion rate. 
An example of this analysis is shown in Figure 2-12B. The two individual populations of droplets 
are clearly observed in both the substrate and product traces. Droplets with high product and low 
substrate signal, and those with low product and high substrate signal were observed in the 
expected alternating fashion. Average instrumental response for high product droplets was 24,200 
± 2,490 and 6,200 ± 1,100 for low product droplets, allowing for the differentiation between 
droplets with and without active enzyme. These results also aligned well with results observed 
from reaction and negative control incubated in microcentrifuge tubes (Figure 2-13), all of which 
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indicates the successful application of the analytical system for the monitoring of enzymatic 
turnover within droplet samples.  
 
Figure 2-12. Evaluation of ATA-117 catalytic activity inside of microfluidic droplets. Samples contained 
100 mM, pH 7 phosphate buffer and the necessary reaction components, as well as 100 µM substrate. 
Negative controls did not have enzyme added. (A) Alternating streams of reaction droplets and negative 
control droplets were converged to create interspersed droplet trains (B) Substrate and product MS-MS 




Figure 2-13. Comparison of droplet incubation and analysis against bulk incubation and continuous 
infusion analysis. Normalized responses for substrate and product signal from droplet introduction of 
sample (Figure 2-12b) as well as from incubation in bulk solution are shown. Bulk reaction solution (1 
mL reaction solution in 2 mL microcentrifuge tube) was introduced directly to the nanoelectrospray 
emitter, without droplet segmentation. Signal was normalized within each pairing shown below. Negative 
reaction took place in absence of ATA-117 enzyme. 
 
Conclusions 
 An interface of microfluidic chips to nESI emitters was found to enable stable nESI-MS 
analysis of droplet samples from 65 pL to 1.2 nL at throughput up to 10 samples/s. Reliable 
performance over hours of operation, corresponding to > 104 samples, is attainable, even when 
monitoring biological samples. By monitoring the enzymatic activity of ATA-117, a possible 
application of the developed system was shown. The success in applying nESI-MS to biological 
droplet samples demonstrates the potential for droplet-based work utilizing MS detection, such as 
monitoring cellular secretions, evaluating enzymatic variants, and rapid biofluid analysis.
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 In vivo Chemical Monitoring at High Spatiotemporal Resolution using 
Microfabricated Sampling Probes and Droplet-Based Microfluidics Coupled to Mass 
Spectrometry 
 
Adapted from Anal. Chem. 2018, 90, 18, 10943-10950. with permission of the American 
Chemical Society. Co-authored with Thitaphat Ngernsutivorakul (primary author) and Alec 
Valenta. 
  
 Contributions of D. Steyer to this work include the development and application of 
nanoelectrospray ionization-mass spectrometry assay for measuring neurochemicals. 
 
Introduction 
 Measuring the concentration dynamics of neurotransmitters and metabolites in vivo is a 
powerful way to investigate brain function127–131. Techniques such as microdialysis 
sampling111,132,133, electrochemical sensors103,134, genetically-encoded sensors135,136, and positron 
emission tomography108,137 have all been used for this purpose. An ideal method would allow high 
temporal and spatial resolution, be minimally invasive, allow multiplexing, and have easily tuned 
selectivity for sensing. None of the techniques currently in use fully meets this ideal; but, each has 
significant strengths so that the methods are largely complementary. Sensors have excellent 
temporal and spatial resolution but tuning the selectivity and measuring several compounds at once 
are significant challenges. Microdialysis allows multicomponent measurements and easily tuned 
51 
 
selectivity; however, temporal and spatial resolution significantly lag sensors. In this work, we 
integrate several recent advances in microfluidics and mass spectrometry (MS) to create a 
sampling and analysis system that has good temporal and spatial resolution but is also readily 
applied to multicomponent measurements and tuned for detecting different compounds. The 
system also integrates a microinjection device for delivering chemicals directly to the site of 
measurement.  
 Microdialysis and related methods involve implanting a sampling device into tissue, 
collecting fractions, and then analyzing them by appropriate methods. Use of methods like high-
performance liquid chromatography (HPLC), capillary electrophoresis (CE), and MS to analyze 
the collected fractions allow multiple targets to be measured (see 110,138 for reviews). Historically 
these methods have not been competitive with sensors with respect to spatial and temporal 
resolution; however, advances over the past 2 decades have reduced the gap. Temporal resolution 
is mostly limited by the time required to collect enough sample for analysis. The coupling of 
microdialysis to miniaturized methods, such as fast capillary LC139,140, direct infusion MS48, and 
CE141–144, has improved temporal resolution from minutes to a few seconds. Temporal resolution 
may also become limited by the dispersion of sampled concentration pulses due to flow and 
diffusion during mass transfer from the sampling device to fraction collector. Collecting samples 
into segmented flow, where each fraction is compartmentalized into a droplet by an immiscible 
fluid, immediately after sampling can prevent such dispersion and allow higher temporal 
resolution36,145,146. This approach has been used for monitoring concentration dynamics in 
vitro145,147 and in vivo48,114,148, allowing temporal resolution of less than 10 s. Several analytical 
methods have been coupled with droplet fraction collection including enzyme assay114,146, 
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electrochemical detection31,32,149, microchip CE36,148, and MS52,145,150. Some of these methods, such 
as CE and MS, preserve the potential for multicomponent analysis and ready adaption to different 
analytes. 
 Spatial resolution of sampling devices has also improved over the original style of 
microdialysis probes, which are 220 - 400 µm diameter × 1 - 4 mm long. Low-flow push-pull 
perfusion offers the best spatial resolution113,114,151. In this method, two capillaries are fixed side-
by-side and sample removed by one capillary while make-up fluid is added through the other 
capillary at flow rates of 50 - 100 nL/min. Sampling occurs only near the inlet/outlet, thus greatly 
improving spatial resolution over microdialysis. Sampling areas are approximately 0.02 mm2 
compared to 0.7 - 5 mm2 for microdialysis. Use of microfabrication allows even smaller probes to 
be made115,152–154. Microfabricated silicon probes that are 85 µm wide × 70 µm thick containing a 
20 µm-square orifices have been reported yielding sampling areas at least 1000-fold smaller than 
a microdialysis probe115. The smaller size is important not only for spatial resolution but also 
reducing invasiveness of the probes. 
 Little work however has been done on converging the improved temporal and spatial 
resolution advances for in vivo monitoring. That is, good temporal resolution has been achieved 
with large probes and better spatial resolution has only been achieved with low temporal 
resolution. In one exception, a hand assembled low-flow push-pull probe was coupled to droplets 
which were analyzed by an enzyme assay for glutamate114. The system achieved 7 s temporal 
resolution but was limited to a single analyte. Recent work has shown utility of a microfabricated 
polymer-based probe (240 µm wide × 86 µm thick) for segmented flow sample pulling prior to a 
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laser ablation inductively coupled plasma MS analysis of metals155. This system allowed collection 
of 18 nL droplets and a temporal resolution of 50 s. 
 In this work, we couple a microfabricated silicon push-pull probe to droplet collection. The 
microfabricated probe also integrates an injector to allow chemical manipulation of the sampled 
area. Collected droplets are analyzed by direct infusion nanoelectrospray ionization (nESI) MS. 
This combination yields samples from a 20 µm × 60 µm area and attains 6 s temporal resolution. 
nESI MS allows multicomponent measurements (4 analytes together with their internal standard 
in this case) and potential tuning for different analytes. The resulting integrated system therefore 
achieves many of the goals of in vivo monitoring.  
 
Experimental Section 
Chemicals and materials 
 Unless otherwise specified, all chemicals were purchased from Fisher Scientific (Fairlawn, 
NJ) or Sigma Aldrich (St. Louise, MO) and were certified ACS grade or better. Solutions were 
prepared with HPLC-grade water, filtered and degassed prior to use. Syringes (Gastight® 1700 
Series, 25 µL or 100 µL) were purchased from Hamilton (Reno, NV). Teflon PFA tubing was 
purchased from IDEX Health & Science (Oak Harbor, WA). Polyimide-coated fused-silica 
capillary was purchased from Molex (Phoenix, AZ). Fast curing epoxy resins were purchased from 
Loctite (Westlake, OH) for a standard type and ITW Devcon (Danvers, MA) for a gel type. 
Polydimethylsiloxane (PDMS) was purchased from Curbell Plastics (Momentive® RTV 615, 
Livonia, MI). Crystalbond™ 555 adhesive was purchased from Structure Probe (West Chester, 
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PA). Artificial cerebrospinal fluid (aCSF) consisted of 145 mM NaCl, 2.68 mM KCl, 1.10 mM 
MgSO4, 1.22 mM CaCl2, 0.50 mM NaH2PO4, and 1.55 mM Na2HPO4, adjusted pH to 7.4 with 0.1 
M NaOH. High-potassium (K+)-aCSF consisted of 100 mM KCl and 47.7 mM NaCl; the other 
components were the same as regular aCSF. 
 
Probe and holder 
 Probes were microfabricated on a 525 µm thick 4-inch silicon wafer (University Wafer, 
MA) as described in detail elsewhere115, with modification in probe design. Briefly, a series of 
microchannels were masked on a wafer by photolithography before the wafer was etched by deep 
reactive ion etching (DRIE) and XeF2 etching. The wafer was sealed with poly Si using low 
pressure chemical vapor deposition. Lithography and DRIE were again used to etch probe shapes 
and sampling orifices with desired dimensions. The wafer was mounted to a carrier wafer with 
Crystalbond™ 555 adhesive and backside etched using DRIE prior to probe release in hot water. 
After probe release, residual adhesive was removed by baking at 610 °C for 8 h in a laboratory 
kiln. 
 The final probe size was 11 mm long, 84 µm wide × 70 µm thick. Probes included 3 
channels of 20 µm i.d. One channel was used for pull flow. Another channel was used for push 
flow. The third channel was merged with the push channel at 500 µm from the probe orifice. This 
additional channel was used for microinjection of a stimulant. Schematics of the probe and its 
operation are shown in Figure 3-1 and 3-2A. For probe handling and sample transfer, a probe was 





 PDMS microchips were designed to couple the probe outlet to flow segmentation and 
reagent addition. The PDMS chips were fabricated using a combination of a standard soft 
lithography technique and a pour over method34. A final device contained a 4-way junction (cross) 
with 125 µm wide × 100 µm tall channels for simultaneous flow segmentation and reagent 
addition, or a 3-way junction (tee) for flow segmentation only. The devices were designed to create 
proper sealing and accommodate ease of connection with standard 150 µm o.d. tubing or 360 µm 
o.d. tubing.  
 
In vitro characterization  
 Device operation. The microfabricated probe was operated similar to capillary-based push-
pull probes with segmented flow sampling114. An outline of the probe integrated with the PDMS 
chip is illustrated in Figure 3-2. Push flow was generated from a syringe pump (Chemyx, Stafford, 
TX) connected to the probe via a 40 cm length of 40 µm i.d. capillary. Pull flow of sampling at 
100 nL/min and reagent addition at 55 nL/min  (measured by observing droplet size and frequency, 
and fluorescent intensity) was generated by 200 mm Hg vacuum applied at one arm of the cross 
that was connected to a length of Teflon tubing to store collected samples. Other arms were 
connected to: 1) the probe outlet, 2) a vial of a fluorinated oil (50:1 v/v 
perfluorodecalin:1H,1H,2H,2H-perfluoro-1-octanol (PFD:PFO), viscosity of 5.1 cps) for flow 
segmentation, and 3) a mixture of internal standards in water for addition to the sample droplets 
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collected from the probe. The mixture of internal standards included 100 µM 13C-glutamine (Gln), 
1 µM 13C-glutamate (Glu), 100 nM 13C-γ-aminobutyric acid (GABA), 20 nM d4-acetylcholine 
(ACh), and 10 µM fluorescein. For some experiments, the probe outlet was connected to a tee to 
by-pass addition of internal standards. 
 Droplet analysis. Analysis of droplets was carried out using fluorescent microscopy for 
fluorescein detection and nESI-MS for neurochemical detection. The droplets were pumped from 
the Teflon storage tubing into a detector using a syringe pump. Fluorescence of droplets were 
imaged by using an inverted fluorescence microscope (Olympus IX71) with a Xe-arc lamp, 
appropriate filters, and a CCD camera (Hamamatsu ImageEM X2). When reagent addition was 
performed, a ratio of added reagents to samples was determined based on the fluorescein intensity 
in aqueous droplets. For the nESI-MS assay, the outlet end of the Teflon tubing was connected to 
a nESI tip using a commercial union (PicoClear™, New Objective, Woburn, MA). nESI emitters 
were made from 50 µm i.d. x 360 µm o.d. fused silica capillary, which was pulled to 15 µm i.d. 
and platinum coated (FS360-50-15-CE, New Objective, Woburn, MA). Sample droplets were 
pumped at 50 nL/min through the nESI tip, except for in experiments where the effect of flow rate 
is being examined. A potential of +1.25 kV was applied to the Pt coating to induce nESI. Samples 
were analyzed using a Micromass Quattro Ultima® triple-quadrupole mass spectrometer (Waters, 
Milford, MA), operated in multiple reaction monitoring (MRM) mode using conditions listed in 
Table 3-1. Data were analyzed by Masslynx 4.1 (Waters, Milfrod, MA). Cutter156 was used for 
data processing, peak detection, and determination of peak intensities. Ratio of the peak intensity 










GABA 104 → 87 150 35 10 
13C-GABA 110 → 93 150 35 10 
ACh 146 → 87 150 35 15 
d4-ACh 150 → 91 150 35 15 
Glu 148 → 130 150 35 10 
13C-Glu 153 → 135 150 35 10 
Gln 147 → 130 150 35 10 
13C-Gln 152 → 135 150 35 10 
Table 3-1. Parameters for nESI-MS-MS detection of neurochemicals and internal standards 
 
In vivo sampling 
 Surgical procedures were similar to those described previously153. Male Sprague-Dawley 
rats weighting between 250 - 350 g were anesthetized using 2 – 4% isoflurane, and placed in a 
stereotaxic frame (Kopf Instrument, Tujunga, CA). Animals were maintained under isoflurane 
over the entire experiment. Probes were stereotaxically inserted to the striatum at coordinates +1.5 
mm anterior, ± 3.0 mm lateral to bregma, and a depth of 4.5 mm ventral from dura. Probes were 
lowered slowly over 1 min. During probe insertion, probe channels were back-flushed at 200 
nL/min to prevent clogging before immediately reducing the flow rate to be 100 nL/min at the 
sampled region. After ~5 min of flow stabilization, an outlet of the pull channel was connected to 
the PDMS cross before generation of pull flow. For equilibration of baseline, push-pull flow was 
continued for at least 30 min before sample collection. K+ stimulation was performed by switching 
a push flow from aCSF to high K+ aCSF through the third channel of the probe. High K+ aCSF 
was perfused at 100 nL/min for 1 min before switching the flow back to regular aCSF.  
 For statistical analysis, data were transformed to percentage of baseline. Statistical software 
R157 and RStudio in conjunction with the lme4 package158 were used to perform a linear mixed-
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effects analysis of the relationship between baseline percentages of each analyte and phases of 
stimulations. As fixed effects, phases of stimulations (pre- or post- stimulation) were entered into 
the model. Animals/subjects were included as random effects. A significance level of 0.05 was 
used for all analyses. Results were statistically significant when P-value is < 0.05. 
 
Results and Discussion 
Probe and microinjector 
 Micromachining of silicon was utilized to fabricate push-pull probes as before115; however, 
in this work we sought to increase the yield of probes and to incorporate a microinjector, which is 
frequently useful in neurochemical experiments. Previously we obtained ~60% yield of useful 
probes with the majority of failures due to clogging. Clogs were most frequently due to the use of 
adhesive (CrystalbondTM 555) during the backside etching step that may enter and clog probe 
channels. To address this problem, we added a step of baking the probes to decompose the adhesive 
after an initial hot water treatment. Visual inspection showed no visible residue and no effects on 
performance were found from the heating step. With this step, fabrication yield was improved to 
90% (10% of the probes were broken during probe release and manual transfer) of 30 probes tested. 
Overall, the current fabrication process was reliable, yielding smooth channels with high 




Figure 3-1. (A) Overview of probe shape and channel. (B) SEM images of microfabricated push pull probe 
with additional channel for microinjection. The images show i) cross section of the probe; ii) top view of 
an integrated tee (after backside etch to reveal the channels); iii) tip of the probe with an estimated sampling 
area yellow dashed). 
 
 Microinjection is frequently used to locally add drugs that modulate neural function. 
Although a separate micropipette can be used, the use of microfabrication allows incorporation of 
an injector into the device (Figure 3-1). The two main channels were used for push and pull flow. 
The additional injector channel was merged with the push channel, creating a tee-junction at 500 
µm above the orifice. Switching the flow at the tee junction allowed microinjection of a stimulant. 
At a flow rate of 100 nL/min, the 10% to 90% rise time of a step concentration change at the probe 
exit was theoretically estimated to be 72 ms114. The time to begin exiting the probe (i.e., the time 
60 
 
required to flush the channel volume) was estimated to be 94 ms based on flow rates and channel 
volumes.  
 Microfabrication allowed limiting the space between the push and pull orifices to be merely 
20 µm (Figure 3-1B, iii). The active sampling area of the probe, which defines the spatial 
resolution, was 20 µm × 60 µm. This sampling area is about 10-fold smaller than that of push-pull 
probe made from capillaries114; although somewhat larger than push-pull probes made by pulling 
glass capillaries to ~30 µm outer diameters159. Compared to a conventional microdialysis probe 
with 2 mm long × 220 µm diameter membrane, spatial resolution of the microfabricated push-pull 
probe is approximately 1000-fold higher. 
 
Droplet generation and multicomponent measurement by MS  
 For analytical measurements it is desirable to add reagents or internal standards to collected 
samples. The microfluidic cross shown in Figure 3-2 was used to add reagent as sample droplets 
were formed. Using our conditions, droplets with approximately 1:1.5 aqueous: PFD/PFO volume 
ratio were generated (see Figure 3-2B, inset) while reagent was added at 1:1.8 reagent: sample 
volume ratio. As shown in Figure 3-3A, reliable sampling and reagent addition could be attained 
with an average of 3% RSD in peak height for serial sampling and reagent additions. By using 150 
µm i.d. Teflon as a storage tube, droplets containing sample and added reagent with the total 
volume of ~7 nL were formed at every about 3 s. Regulation of pull flow rates was achieved based 
on flow resistance of the tubing connected to each arm of the cross. In other words, desired flow 
rates of sample, PFD/PFO, and reagent could be achieved by selecting appropriate capillary 
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geometries and applied vacuum pressure and estimated by using the Hagen-Poiseuille equation. 
For in vivo experiments, flow rate of PFD/PFO (which correlated to carrier fluid space) was 
reduced to facilitate more numbers of collected samples per a storage tube.   
 
Figure 3-2. Overview of experimental setup for monitoring brain chemical dynamics with high 
spatiotemporal resolution. (A) Microfabricated push-pull probe with 3 channels. The first and second 
channels were used for pushing regular aCSF and microinjection of K+-aCSF. The last channel was used 
for pulling sample. The inset showed microfluidic interface between the probe and a “fluidic” capillary. 
This capillary was used for sample transfer prior to connecting with a microfabricated cross for 
simultaneous flow segmentation and reagent addition. (B) Generated droplets were collected in a Teflon 
storage tubing prior to an offline analysis. The inset showed a microscopic photograph of the flow 
segmentation with reagent addition. Food dyes were added to sample and reagent for visualization. (C) 




Figure 3-3. In vitro characterization of sampling coupled to segmented flow and reagent addition. Samples 
were a mixture of standards in aCSF and reagents contained fluorescein and a mixture of internal standards. 
(A) Detection of fluroescein in droplets yielded peak heights with RSD of 3% (n = 3 device sets). An 
example of a step change of Gln during switching concentration is shown in (B) along with related internal 
standard added at the same period. (C) Calibration curves from ratio of signal traces of standards to internal 
standards. Linear calibration curves were achieved. 
 
 Direct infusion nESI-MS was utilized for analysis of collected droplets. Pilot experiments 
revealed that low infusion flow rates were necessary to enable detection of the amino acids in 
aCSF. As shown in Figure 3-4, decreasing the flow rate of infusion allowed significantly better 
discrimination against background. This improvement can be attributed to the nanospray effect, 
i.e. low infusion rates reduce ionization suppression and matrix effects. This is important as the 
63 
 
high salt content of aCSF and the complex sample matrix can greatly suppress ionization of other 
compounds. 
 
Figure 3-4. Comparison of signals obtained for MS/MS of 1 µM GABA dissolved in aCSF at (A) 50 
nL/min; (B) 300 nL/min; and (C) 800 nL/min. Each trace shows the signal intensity for the 104 → 87 m/z 
transition for 10 droplets. The first 5 contained GABA and the last 5 were aCSF only. For (A) and (B) each 
droplet was 4 nL and spaced by 4 nL carrier fluid. For (C) each droplet was 10 nL spaced by 10 nL carrier 
fluid. 
 
 In this work, we measured 3 neurotransmitters (Glu, GABA and Ach) and Gln, a metabolite 
of Glu. The effect of flow rate (50-300 nL/min) on the detection of all four is shown in Figure 3-
5. For this experiment, 100 nM Ach, 1000 nM GABA and Glu, and 10µM Gln were all dissolved 
into aCSF and formed into 4 nL droplets, which was alternated with blank aCSF every 10 droplets. 
In this case, steps in flow rate were closer, with analysis performed at 50, 100, 200, and 300 nL/min 
to give more detail as to where flow rate dependent effects are seen. Ach (Figure 3-5B) was the 
only analyte that gave no discernable trend with flow rate; however, this particular 
neurotransmitter has been shown to be compatible with higher flow ESI-MS.48 The other 3 all 
showed significant improvements at lower flow rates. When moving from 300 nL/min infusion to 





















50 nL/min, the observed signal-to-noise (S/N) values for GABA, Glu, and Gln were enhanced by 
3.6x, 4.8x and 1.8x respectively. With this improvement in mind, we used an infusion rate of 50 
nL/min for all assays. 
 
Figure 3-5. Effect of flow rate on the nESI-MS-MS detection of GABA (A), ACh (B), Gln (C) and Glu 
(D) from aCSF. Left bars in each pairing (blue) represent average signal for analyte containing droplets. 
Right bars (green) represent S/N value, which was found by comparing MS-MS responses from analyte 
containing droplets and blank droplets (n=9 for each). GABA MS-MS signal (104→87) above baseline 
electronic background was not observed for blank droplets, so noise was calculated from average of 
background during time when blank droplets were expected to be seen. 
 
 Using an infusion flow rate of 50 nL/min, droplets were reliably transferred to the nESI tip 
and allowed collection of 7 - 8 data points per droplet during multiple reaction monitoring. Using 
the microfluidic cross (Figure 3-2), a stable isotope labeled internal standard of each analyte was 
added via the reagent addition channel during sample collection. The internal standard allowed for 
normalizing the effect of matrix and instrument drift on signals.  
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 Temporal resolution and sensitivity of the method were characterized in vitro by sampling 
from a stirred vial of a mixture of the 4 analytes in aCSF. An example of droplet analysis for 
monitoring Gln is illustrated in Figure 3-3B. The rise time during concentration change was ~6 s 
(2 droplets) at a sampling rate of 100 nL/min. Hence, temporal resolution was not limited by 
reagent addition, sample storage before analysis (1-3 h), or the MS assay. Calibration curves were 
obtained with good linearity (R2 values were >0.95) and the dynamic range covered expected in 
vivo concentrations of each analyte (Figure 3-3C). The assay was reasonably reproducible with 
RSDs of the peak intensity ratios in the range of 6 - 11%. Using a signal to noise (peak to peak) 
ratio of 2, the limits of detection (LODs) were 90 nM for Gln, 60 nM for Glu, 20 nM for GABA, 
and 2 nM for ACh. 
 
In vivo monitoring of neurotransmitter dynamics 
 The complete system (microfabricated probe with microinjection, droplet-based microchip 
with addition of internal standards, and nESI-MS assay) was used for in vivo neurochemical 
monitoring. Basal concentrations of the analytes were estimated to be 6.4 ± 2.3 µM for Gln, 0.20 
± 0.05 µM for Glu, 62 ± 10 nM for GABA, and 2.3 ± 0.7 nM for ACh (mean ± SEM, n = 4 animals; 
at least 50 samples for each animal). These concentrations were not corrected for recovery; 
however, in vitro recoveries of the probe were measured to be 83 ± 3%, 47 ± 10%, and 18 ± 7% 
(n = 5) by sampling fluorescein at a perfusion rate of 100 nL/min, in a stirred vial, a non-stirred 
vial, and a 0.6% agarose gel160, respectively. The ACh concentrations were near the LOD and 
therefore this neurotransmitter was not as reliably detected as the others.  
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 In general, the sampled concentrations measured in this experiment were lower than those 
previously reported for the same brain region84,113–115,153,161–172. Gln is typically found in several 
hundred micromolar concentrations but we found it to be below 10 µM. The reports for basal 
concentration of Glu have been variable with a ranges of 1 – 5 µM for sampling studies and 2 - 18 
µM for microelectrode studies171; however, in this study we observed 0.20 µM. GABA has been 
reported in the range of 300 – 700 nM while we observed 60 nM. ACh was generally about 30 nM 
but we observed < 4 nM.  
 The lower concentrations could be due to a variety of factors. Most significantly, our 
concentrations are not corrected for recovery as it is not yet known how recovery for low-flow 
push-pull perfusion is altered in vivo. If recovery is similar to sampling from agar gel, where we 
observed about 18% recovery, then our concentrations would be similar to previous reports. Also, 
it is possible that pull flow rates during sampling were lower than the nominal 100 nL/min which 
in turn would lower observed recovery. Although flow in vivo was initially set to be 100 nL/min, 
it is possible that during the experiment clogs developed that slowed the flow. (Lower flow rates 
of sample would result in droplets that were more diluted by the internal standard solution, which 
is added at a fixed rate, and appear as a lower concentration of analyte in the droplet. If there is a 
mismatch in push and pull flow rates, then we may preferentially sample from the push volume 
and obtain a lower concentration.) Similarly, the excess volume injected during probe lowering 
(both channels backflushed at 200 nL/min) might create a volume that dilutes neurotransmitters if 
it did not dissipate. Other variables that can affect recovered concentrations include anesthesia, 
probe size, and probe geometry173.  
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 To demonstrate capability of the system for detection of rapid chemical changes, 
microinjection of 100 mM K+-aCSF was performed to stimulate neurochemical release. As shown 
in Figure 3-6, microinjections of high K+ solution evoked transient increases that lasted < 30 s, yet 
could be captured by this method, for all analytes. For the first injection, the changes at peak 
maximum from the baselines were 500 ± 120% for Gln, 810 ± 390% for Glu, 1800 ± 1300% for 
GABA, and 620 ± 280% for ACh (mean ± SEM, n = 4). For a subsequent injection, the average 
increases were 430 ± 120% for Gln, 330 ± 130% for Glu, 790 ± 500% for GABA, and 300 ± 110 
% for ACh. The percent increase in Glu was similar to previous work114,143,148,163,171,172,174. In 
addition, substantial effect of K+ stimulation on GABA levels was also in agreement with the 
previous studies148,163,165. Increases in ACh were also similar to other previous reports175–177. 
However, we observed increases in Gln while other work reported decreases in Gln levels after K+ 
stimulation. The reasons for this discrepancy are unclear. The other approaches perfused a high-
K+ solution for a much longer time178–182. The prolonged exposure of brain tissues to the solution 
could alter the dynamics observed175,183. Furthermore, the other work used larger probe sizes and 
collected and analyzed samples at fractions of several minutes. These spatial and temporal 
differences may ultimately yield different results. Variability observed in the stimulated responses 
is reasonable; but could be due to a variety of factors including: 1) if rapid changes occurred the 
temporal resolution may distort them, i.e. we may have insufficient sampling rate; 2) spatial 
heterogeneity in the brain may result in different responses from the small probe size; 3) complex 
fluid dynamics may arise from having the injector close to the sampling probe that might cause 
some variability; and 4) variability in the start of the syringe pump may affect the amount and 




Figure 3-6. In vivo monitoring of response to microinjection of 100 mM K+-aCSF in the rat striatum. (A) 
shows an example trace for simultaneous responses of Gln (i), Glu (ii), GABA (iii) and ACh (iv). Arrows 
indicate beginning of microinjection. Rise times could be observed within 3 droplets or ~9 s. (B) shows 
averaged responses of Gln (i), Glu (ii), GABA (iii) and ACh (iv), (mean ± SEM, n = 4 rats). Data were 
expressed as percentages of the averaged baseline values during pre-stimulation levels. Dashed lines 
indicate periods of K+-stimulation. Linear-mixed effects models indicate significant changes (*, p < 0.05) 
between basal and stimulation phases. 
 
 The rise time for K+ response was 15 ± 3 s. This rise time is slower than the temporal 
resolution of the monitoring system. The slower rise time was likely due to the use of a syringe 
pump for microinjections, which typically required at least 5 – 10 s before reaching the desired 
perfusion rate. Importantly though, these in vivo experiments illustrate the capability of the 
microfabricated probe and analysis system for achieving both high spatiotemporal resolution and 
multiplexed neurochemical monitoring.  
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 Although the probes cannot sample from single synapses, the spatial resolution should be 
sufficient for monitoring chemical activity in small brain regions or detecting heterogeneity in 
larger brain nuclei. The temporal resolution achieved is not sufficient to detect single exocytotic 
events or release from single action potentials. However, these dynamics will be useful in tracking 
changes that occur during behaviors and response to rapid stimuli. 
 The nESI-MS system was sufficiently robust for relatively long-term monitoring, even 
from saline samples. Extended operation of a nESI emitter can lead to crystallization of inorganic 
salts118,184, which we did observe when directly infusing aCSF in a continuous fashion (Figure 3-
7A). The use of pulsed nESI voltage, in place of applying a constant voltage, has been shown as a 
way to provide stable spray over long periods of time, which was attributed to a self-cleaning 
effect118. By segmenting droplets with PFD/PFO carrier phase, we found that experiments lasting 
an hour or longer were routinely possible. A similar self-cleaning effect may be happening, where 
aqueous droplets approaching the tip can redissolve any crystallized salts before contacting the 
electrically conductive exterior surrounding the spray orifice. Figure 2-6B illustrates an example 
of analysis of 400 droplets over 100 minutes, with no interruptions in the nESI process observed. 
This process can then be performed for multiple droplet trains on the same emitter by simply 




Figure 3-7. (A) Formed salt crystal from on nESI emitter after 15 min of aCSF electrospray, indicated by 
blue arrow. Formation of salt crystals can negatively affect nESI-MS signal and even totally block flow. 
Segmenting sample stream with PFD/PFO was found to drastically reduce salt crystallization during nESI  
(B) Raw MS/MS data for GABA from in vivo collection. ~5 nL brain samples were infused with 
segmenting fluid at 50 nL/min for 100 min, corresponding to about 400 samples. The two increases in 
signal correspond to K+ infusions. 
 
 Operation of the system revealed some areas for improvement in sampling. During in vivo 
experiments, we occasionally observed disturbance of segmented-sampling flow that led to flow 
blockage or eventual clogging. The origin of the cause of flow disruption is still not clear. The 
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cause of this disruption might be due to tissue debris at the probe inlet185. In addition, it is possible 
that variations in intracranial pressure (caused by several factors, such as surgery procedures and 
brain exposure to local room pressure154), flow rate of CSF186,187, and viscosity of sampled 
fluid188,189 can affect to disturbance of microfluidic flow. Although these variations were not 
previously reported to be an issue in other low-flow push-pull studies113,114,174, their negative 
effects on device operation might become significant in miniaturized sampling with segmented 
flow (i.e., when active sampling area and fraction volumes are extremely small). Further work is 
required to understand these effects. Development and use of integrated, automated pressure 
controller and flow meter will help to accordingly adjust microfluidic flows and overcome the 
above issue. The use of low flow rates to achieve nESI enabled overcoming ionization suppression 
sufficient to allow detection of the compounds tested here. Further work will be required to 
determine if direct infusion will allow detection of other neurotransmitters and metabolites.  
 
Conclusion 
 The combination of microfabricated push-pull sampling probes, flow-segmentation, and 
direct nESI-MS of droplets yields a system that can achieve 5-10 s temporal resolution for 
monitoring molecules with a spatial resolution and low invasiveness that is comparable to most 
sensors while retaining the multiplexing and ability to tune selectivity that is afforded by MS. 
Thus, this approach achieves several of the important goals for in vivo monitoring. It is likely 
possible to achieve a sub-second temporal resolution with further refinements. Further work is 
needed to better understand in vivo recovery with the probes as well as mitigate causes of flow 
disturbance. Further work is also required to learn how applicable this approach will be to different 
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chemical targets. The method is limited by the ability to overcome ionization suppression and the 
sensitivity of the mass spectrometer used. Newer instruments and on-line sample preparation of 
the droplets should expand the number of analytes detectable by this approach. The use of 
microfabrication for creating probes is a significant benefit. For example, in this case a 
microinjector was directly incorporated into the device. In principle it may be possible to integrate 
other features, such as electrodes for electrophysiological recording. In addition to in vivo 
neurochemical monitoring, the technology developed here maybe adaptable to other 
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 Contributions of D. Steyer to this work include the development and implementation of 
droplet generation methods, MS assays, and statistical analyses. 
 
Introduction 
 In the search for breakthrough medicines, materials, and agrichemicals, the accelerated 
preparation of complex small molecules in a miniaturized fashion can have a profound impact on 
reducing chemical footprint while expanding upon reaction space.72–75 High throughput 
experimentation (HTE) technology offers avenues for rapid data collection and process 
automation, and its implementation in organic synthesis has enabled the expedited discovery and 
optimization of various reaction manifolds.69,70 From a pharmaceutical standpoint, the rapid 
development and application of novel synthetic methodology plays a central role in accelerating 
access to highly functionalized drug leads. Given the short supply of substrate libraries at the start 
of a drug discovery program, it is often necessary to decrease the scale of experimentation to access 
broader chemical space.72,74 The use of HTE techniques represents a streamlined approach for 
enabling the exploration of a myriad of catalysts and reaction conditions in a time and resource-
efficient manner. Recent advances in miniaturized HTE have supported the diversification of 
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expansive pharmaceutical libraries via palladium-catalyzed C–C, C–O, and C–N bond forming 
reactions at nanomole scale, using both continuous flow and plate-based approaches.79,80,190,191 
Furthermore, platforms that integrate high throughput reaction optimization with subsequent 
biological evaluation provide additional opportunities for streamlining bioactive molecular 
discovery.72,190 
 The combined objectives of rapid reaction screening and product analysis are contingent 
upon integration of high throughput analytical instrumentation to provide near real-time data 
collection. Conventional screening methodologies rely on optical detection platforms, like plate 
readers, to rapidly assess reaction progress. While these methods provide high throughput levels, 
reactions can be difficult to directly monitor if they lack a change in optical response upon product 
formation or there are high optical backgrounds associated with reaction matrices, often 
necessitating the application of time-intensive chemical separations, optical labelling of substrates, 
monitoring of side products, or the addition of secondary reactions. Mass spectrometry (MS) 
detection has been demonstrated as an enabling technology in HTE, due to the high degree of 
chemical information and specificity imparted in its measurements.79,80 The application of rapid 
liquid chromatography and solid phase extraction techniques have led to the electrospray 
ionization (ESI)-MS-based analysis upwards of 5 s/sample.79,80,83 Alternatively, direct analysis of 
samples by MS has enabled even higher throughputs. Commercially available flow injection ESI-
MS systems can access throughputs as high as 2.5 s/sample.83,192 Ionization methods based on 
plating samples, such as matrix-assisted laser desorption (MALDI) and desorption electrospray 
ionization (DESI) both have potential for rapid synthetic sample analysis and have been 
demonstrated at throughputs exceeding 1 sample/s.193–195 Acoustic mist systems for the generation 
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of nL volume droplets have found use both in the transfer of sample for a variety of MS-based 
analyses, as well as in the direct formation of gaseous ions for MS analysis at a rate of 3 
samples/s.196–199   
 While the above approaches present impressive capabilities in MS-based HTE, interfacing 
MS with droplet microfluidics can unlock further avenues in HTE.  Droplet microfluidics is a 
powerful approach for sample processing. Discrete fL-µL volume “droplet” samples are isolated 
by an immiscible carrier phase and can be rapidly manipulated.  As a result, droplet microfluidics 
has found utility across a variety of biological and chemical applications. Pairing droplet 
microfluidics with MS, typically through ESI or MALDI, has produced powerful systems for HT 
work39,41,43,44,46,86. NanoESI (nESI) is a nL/min flow variant on conventional ESI and presents 
significant advantages in sensitivity and matrix tolerance, compatibility with low volume samples, 
and observation of structurally unstable molecules through very gentle ionization. Application of 
nESI-MS has created systems for monitoring the molecular content of pL-nL volume droplets with 
high analytical stability at throughputs as high as 10 droplets/s.42,85,200 As it stands, work 
combining droplet microfluidics and MS for synthetic applications has been very limited in 
scope.86 The development of new droplet microfluidic MS approaches and application to chemical 
transformations of rising interest is therefore necessary to drive further innovations in HTE.  
Over the past decade, photoredox catalysis has risen to the forefront of organic synthesis 
by enabling otherwise infeasible bond disconnections and aiding in sustainability efforts through 
the use of visible light.201–204  In addition to the promise of reduced waste streams and the 
avoidance of hazardous and toxic reagents classically employed for carbon-centered radical 
formation (e.g. tributyltin hydride, BEt3/O2, azobisisobutyronitrile), photoredox catalysis has 
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gained meaningful traction in industrial applications due to its ability to interface with continuous 
flow technology during process scale-up. With the goal of facilitating the rapid exploration and 
optimization of photoredox reactions, we have applied segmented droplet flow with MS towards 
designing a high throughput screening platform to expand upon the robust capabilities and impact 
of photoredox catalysis in drug discovery and development. Screening of photoredox catalysis 
fluoroalkylation reactions was performed with the concerted objectives of enabling reaction 
discovery and high throughput optimization of ‘hit’ reaction conditions. ESI-MS analysis 
throughput as high as 2.9 droplets/s and methods for accounting for ionization in variable sample 
matrices were demonstrated, providing a system for the rapid and robust MS analysis of 




 Perfluorodecalin (PFD) was purchased from Oakwood Products (Estill, SC).  All other 
reagents were purchased from Fisher Scientific or Millipore Sigma. Compounds used in 
fluoroalkylation screening were generously provided by Pfizer. 
 
Reagent Preparation for Fluoroalkylation Reactions 
            1 mol% photocatalyst and 4 equivalents of N-oxide reagent were dissolved in acetonitrile. 
The reagent solutions were sparged with a stream of nitrogen gas for 5 min. 4.4 equivalents of 
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acetic anhydride reagent were subsequently added, and the mixtures were stirred for 10 min to 
facilitate complete conversion to the acylated species. Separate solutions of substrate in acetonitrile 
(0.1 M), with cosolvent when applicable, were also prepared. 10 µL of each solution were mixed 
together in 384 MWPs to form final reaction solution. 
 
Irradiation Chamber Setup 
 A 25 LED array of Cree Royal Blue XTE LEDs (2 W per LED, 50 W total output) was 
assembled to accommodate the dimensions of a standard 96, 384, or 1536 MWPs (Figure 4-1). 
The LEDs were mounted onto a heat sink, with two fans placed below and adjacent to the heat 
sink, in order to provide sufficient cooling to maintain reactions at ambient temperatures. An 
acrylic shield positioned 5 cm above the LED array provided a mounting stage for the well plate, 
as well as an additional layer of protection for the LEDs.  A custom-built plastic amber light shield 
was placed around the setup for user eye protection.  
 
Figure 4-1. (Left) Setup for irradiation of MWP with blue LED lights (Middle) Close-up view of irradiation 




 Before generation, all samples were diluted down 500:1 by a 50:50 methanol:water 
solution w/0.5% formic acid, with the exception of  the trifluoromethylation condition screen, in 
which samples were diluted down to an additional 4:1 with acetonitrile. Droplet plugs were 
generated from microwell plates using equipment and methods described in our previous work.41 
Briefly, samples were drawn into either 100 or 150 µm inner diameter (i.d) x 360 µm outer 
diameter (o.d) perfluoroalkoxyalkane (PFA) tubing (IDEX Health and Science, Oak Harbor, WA) 
by a PHD 2000 Programmable syringe pump (Harvard Apparatus, Holliston, TX). Samples of 8 
µL in volume were deposited into 384-microwell PCR plates (Corning, Corning, NY) with PFD 
placed on top. To form the droplet samples, an XYZ-position manipulator moved the tubing 
between sample wells and fluorous phase while the syringe was continuously withdrawing. When 
diluted only with methanol:water diluent, 8 nL droplets with 12 nL perfluorodecalin spacing were 
generated at 800 nL/min, except when otherwise stated. When additional acetonitrile dilution was 
performed, droplets were found to be less stable, so 6 nL droplets with 10 nL spacing were 
generated at a flow rate of 600 nL/min . 
 
nESI-MS and ESI-MS Analysis 
 Connections from PFA tubing to nanoelectrospray emitters were formed using zero dead-
volume PicoclearTM unions (New Objective, Woburn, MA). nESI emitters were pulled from 75 or 
100 µm i.d. x 360 µm o.d. fused silica capillary to an i.d. of 30 µm (FS360-50-30-CE, New 
Objective, Woburn, MA). Electrospray potential of 1.75 kV was applied to the exterior of the 
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platinum coated emitters, with 35 V applied to the sample cone. Mass spectrometry analysis was 
performed on a Micromass Quattro Ultima triple-quadrupole mass spectrometer (Waters, Milford, 
MA). Nitrogen cone gas emerging from sampling inlet was set to 125 L/h to help stabilize the 
electrospray. For data analysis in MS-only scanning, droplet response was reported as the average 
of three data points in the center of each droplet. For MS-MS analysis, 5 data points were used. 
Flow rates to nESI-MS analysis matched droplet generation flow rates, except in experiments 
testing higher throughputs, which were flowed at 1500 nL/min. For work using a standard 
electrospray source, ESI voltage was 3.0 kV, the source was heated to 100 ºC, the cone gas was 
set at 225 L/h, the desolvation gas was 300 L/h and 200 ºC. The nebulizing gas flow was not 
measured, but it was adjusted to one half turn of the dial. 
 
Results and Discussion 
Droplet nESI-MS Platform Development 
 Our studies into leveraging droplet microfluidics technology for reaction discovery 
centered on the development of a nESI-MS platform for characterizing visible light-driven late-
stage functionalization reactions. We chose to employ a radical perfluoroalkylation protocol, 
developed by the Stephenson group in 2015,205 as a model reactive system for the diversification 
of pharmaceutical compound libraries. As such, we have developed a droplet microfluidics-based 
HTE platform that interfaces nESI-MS analysis with a custom-built plate-based photoreactor to 
accommodate the rapid screening of complex drug molecule libraries. We envisioned that this 
setup would be amenable to applications including the late-stage functionalization of drug 
scaffolds and rapid optimization of substrate-specific reaction conditions.   
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 The workflow for droplet generation involved loading a pre-mixed stock solution into 
MWPs, followed by exposure to blue light. A small fraction of each reaction was then withdrawn 
and diluted. The dilution served to both quench the reaction and aid in MS analysis, as the analysis 
of high concentration (> 1 mM) analytes can lead to saturation of MS signal and contamination of 
the MS source. 8 L of each diluted reaction mixture was deposited into a separate well plate and 
covered with PFD for subsequent droplet formation in PFA tubing.  
To demonstrate the general capabilities of our system, samples were formed from the 
trifluoromethylation reactions of N-Boc-5-bromo-7-azaindole (azaindole) and caffeine substrates 
(Figure 4-2A). Droplets were formed in a repeating 3x3 fashion. Analysis of 8 nL droplets was 
performed at 0.67 droplets/s, allowing for triplicate analysis to be performed in under 5 s. 
Throughput in this experiment was limited by the rate at which our mass spectrometer could scan 
the desired region, which required 170 ms to scan the range of 75-750 m/z. By extracting out the 
m/z values associated for expected products (m/z 263 for trifluoromethyl caffeine, m/z 365 for 
trifluoromethyl azaindole), we were able to monitor the formation of the two products. As seen in 
Figure 4-2B, two separate populations of droplets can be observed in the anticipated 3x3 fashion. 
Droplets that show high response for formation of product in one trace show low response in the 
other, as well as the patterns being offset in the two traces. This result not only attests ability in 
our developed method to observe the formation of product from our TFM reactions, but also to 




Figure 4-2. (A) Reaction scheme for the trifluoromethylation of caffeine and azaindole substrates (B) 
Droplet nESI-MS analysis of caffeine and azaindole trifluoromethylation reactions. Droplet trains of 
repeating 3x3 format were flowed at to nESI-MS analysis at a rate of 0.67 droplets/s. The two traces 
represent the extracted m/z for the azaindole (m/z=367, top) and caffeine (m/z=263, bottom) products. Bars 




 We found that nESI could promote the formation of molecular ions even when ESI could 
not (Figure 4-3), further highlighting the potential utility of a nESI-MS in screening applications. 
Samples composed of 50 mM trifluoromethyl azaindole before dilution were examined by both 
nESI-MS and ESI-MS analysis. nESI-MS analysis of sample containing analyte at a flow rate of 
800 nL/min yielded spectra that showed the intact MH+ molecular ion at m/z=365 and 367, along 
with prominent fragments at 309 and 311. MS-MS analysis of the 365 m/z ion showed the 
formation of the m/z=309 ion with very little energy applied, validating it as a fragment of the 
original molecular ion. When using the standard ESI source with sample flow at 100 µL/min, the 
molecular ion was not visible as nearly complete fragmentation was observed. While some 
fragmentations can be easily predicted (e.g. Boc protection), predicting fragmentation patterns and 
performing more in-depth structural assignments would not be amenable to HT work, making an 




Figure 4-3. Comparison of ESI and nESI analysis of trifluoromethyl azaindole, with predicted structures 
for intact molecule (Right) and loss of t-butyl group (Left). Arrows point to m/z peaks associated with each 
structure. (Top) nESI-MS analysis affording observation of the labile MH+ molecular ion. While the 
309/311 m/z fragments are the most prominent, the 365/367 m/z molecular ions were readily apparent. 
(Middle) nESI-MS-MS analysis of 365 m/z ion at 10 eV collision energy. Fragmentation of the 365 m/z 
ion showed almost complete conversion to 309 m/z ion, validating that molecular ions can fragment to form 
the 309/311 m/z ions observed in MS spectra. (Bottom) ESI-MS analysis of same sample. In this spectrum, 





Accelerated Late-Stage Functionalization of Drug Compound Libraries 
 With the developed system, we aimed to achieve two goals: (1) accomplish late-stage 
functionalization using diverse radical coupling partners and (2) perform the high throughput 
optimization of reaction conditions for individual drug scaffolds. To achieve our first goal of 
performing the late-stage functionalization of complex drug molecules, we carried out the 
fluoroalkylation (CF3, CF2H, CF2Cl) of 17 drug and drug-like compounds (Figures 4-4 and 4-5a). 
In these studies, we ran our reactions in a 384 polypropylene well plate to enable the preparation 
and high throughput screening of heterogeneous reaction conditions. As such, mixtures were 
irradiated with blue light for 1 h in a 384 MWP prior to dilution and subsequent droplet generation 
for ESI-MS analysis.  A sample containing no added substrate was run for each type of 
fluoroalkylation reaction as a control. With this control in place, we were able to differentiate 
between MS signals derived from the reaction of interest and signals that were simply artifacts of 




Figure 4-4. Compounds used in for reaction screen. Compound numbers increase going down columns. 




 At the start of each run, 10 control droplets were analyzed, followed by triplicate samples 
for each of the compounds from the library. Shown in Figure 4-5B is the extracted mass trace for 
the product of compound 1, Verapamil HCl. When analysis of the droplets containing compound 
1 was performed, a dramatic spike in signal is observed in comparison to the control, which is an 
indicator of the successful formation of product. This same approach was applied to each of the 
tested substrates. To give a standardized qualitative measure of which reactions would be 
considered a “hit”, a two-sample t-test was performed, in which each reaction of interest was 
compared against the control reaction to see if signal was significantly increased (Figure 4-5C). 
Reactions were deemed a hit if they achieved a P<0.01. Use of this measure also served to validate 
our screening approach. Across 5 separate substrates, significant increases by full scan ESI-MS 
analysis were observed for all three fluoroalkylations, giving confidence that our method can 
successfully detect product formation across a variety of molecules. Also considered was the use 
of MS counts to show the strength of hits. The log10(product response-control response) was used 
to gauge the magnitude of the signal increase and highlight which reactions were especially 
promising. A common trend across hit reactions is the presence of electron rich functionalities 
including furans, alkylated arenes, and indole derivatives. The fluoroalkyl radicals are electron 
deficient and can couple more easily with electron rich arene/heteroarene substrates. Looking at 
the structural features of the "no hit" compounds, the presence of alkyl amine motifs (e.g. 





Figure 4-5. Screen for late-stage fluoroalkylation functionalization of drug and drug-like compounds by 
droplet nESI-MS. (A) General scheme for fluoroalkylation of 17-compound library. (B) Mass trace for 
predicted product of verapamil (compound 1) TFM reaction. Displayed is the m/z = 523, which is predicted 
MH+ ion of verapamil containing a single TFM group. (C) Results from screen. Coloration on heat map 
describes increased response for desired product MH+ ion over control, while blue stars denote statistical 




High Throughput Reaction Optimization 
 In addition to enabling the accelerated late-stage functionalization of diverse 
pharmaceuticals, our screening platform can also be utilized for the high throughput optimization 
of photoredox reaction conditions. To explore capability in such applications, we aimed to test a 
broad set of conditions for the trifluoromethylation of caffeine and discover new conditions for 
enhancing  product formation. To make this type of work possible, an analytical method needed 
to be established to measure product conversion while tolerating sample-to-sample variability in 
product response due to matrix effects. Our efforts focused on minimizing background signals and 
accounting for variations in ionization efficiency. To lower background signal, MS-MS analysis 
was performed to target a specific fragmentation pattern demonstrated by the trifluoromethylated 
caffeine analyte (m/z = 263→206). The development of an MS-MS assay will reduce or even 
remove backgrounds by increasing the assay specificity towards the product of interest. The 
second point is a general concern in the direct analysis of samples by MS. Changes in the sample 
matrix can drastically affect analyte ionization and observed MS response. This effect is typically 
resolved  through sample cleanup methods such as liquid chromatography and chemical 
extractions. Because the use of such methods is time-intensive, we aimed to implement 
methodologies that would allow for the direct analysis of droplet samples. 
 Shown in Figure 4-6 are the MS traces associated with the detection of trifluoromethylated  
caffeine in the presence of suppressing solvents. Trifluoromethylated  caffeine analyte was 
dissolved in either acetonitrile (50 mM), or in acetonitrile with 4% of either N-methyl-2-
pyrollidone (NMP), dimethylformamide (DMF), or dimethylacetamide (DMA) present. These 
represent commonly used co-solvents in photoredox reactions for enhancing solubility of polar 
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substrates, and even after diluting samples 500:1, were found to have a major effect on analyte 
ionization. In the presence of cosolvent, analyte response was found to observe nearly a 4-fold 
drop, even though analyte concentration remained constant, which would have major ramifications 
in a condition screen. 
 
Figure 4-6. Analysis of trifluoromethylated caffeine in presence of suppressing cosolvents. (Top) MS 
trace for TFM caffeine (m/z = 263). Droplet samples over the first 13 seconds of analysis were dissolved 
in pure acetonitrile. The following droplets had one of the cosolvents present and saw massively 
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decreased response for the trifluoromethylated caffeine. (2nd, 3rd and 4th traces) In descending order, the 
MS traces for NMP (m/ z= 100), DMA (m/z = 88) and DMF (m/z = 74). 
 
 To overcome matrix effects, we explored three methods: the use of standard addition, 
internal standard, and higher dilution factor. (Figures 4-7,4-8,4-9). For these experiments, sample 
solution was composed of 30 mM TFM caffeine in reaction mixture, which was then diluted 1:1 
with either 0%, 8% or 20% DMF in acetonitrile. Graphical representation of performance is in 
figure 4-10. The first method was the use of standard addition, which is a commonly employed 
tactic for addressing samples that have unknown matrix effects (Figure 4-7). For this approach, 
each sample of interest was further split into two samples to analyze. The first was made by the 
previously described 500:1 dilution. The second used the same dilution solvent with 15 µM 
trifluoromethylated caffeine standard present. Because both samples contain the same matrices 
and therefore similar analyte ionization efficiencies, taking the ratio of the two responses gives a 
measure of analyte concentration that accounts for matrix effects. The second method was the 
addition of an internal standard (Figure 4-8). For our caffeine trifluoromethylation reaction, we 
chose to use trifluoromethylated ethyl theophylline as the internal standard, as it only varies in 
structure by a single methylene group. This change is easily discernable by MS but should not 
significantly affect ionization. Trifluoromethyl ethyl theophylline was present in the dilution phase 
at a concentration of 30 µM. For each droplet sample, the response for analyte could be normalized 
against internal standard, which should show similar changes in ionization from variable matrices. 
Finally, the use of a higher dilution factor (10,000x vs. 500x) was examined (Figure 4-9). By 
increasing the dilution and therefore further reducing the concentration of matrix components, we 




Figure 4-7. Trifluoromethyl caffeine MS-MS trace (m/z = 263→206) for standard addition method. 
Droplets with “A” designation were diluted normally, while “B” designation denotes droplets that were 
diluted with additional  solution. 0% DMF (blue bar), 4% DMF (grey bar), and 10% DMF (green bar) 
showed variable ionization, but by normalizing A samples against B samples (A/B), these changes can be 





Figure 4-8. TFM caffeine MS-MS trace (m/z = 263→206, top) and TFM ethyl theophylline (m/z = 
277→192, bottom) for internal standard method. 0% DMF (blue bar), 4% DMF (grey bar), and 10% DMF 
(green bar) showed variable ionization, but by normalizing each droplet’s analyte response against its 









Figure 4-9. TFM caffeine MS-MS trace (m/z = 263→206) for high dilution method. 0% DMF (blue bar), 






Figure 4-10. Comparison of performance across high dilution, standard addition (Std. Add.) and internal 
standard (I.S.) methods for addressing variable trifluoromethyl caffeine ionization in droplet nESI-MS-MS 
analysis. Each bar represents the results from 15 separate samples analyzed in triplicate. Control samples 
were trifluoromethyl caffeine response from base conditions with no extra measures employed. Responses 
are normalized within each method. 
 
 Each of the examined methods have associated strengths and weaknesses. The standard 
addition method directly accounts for matrix effects but halves throughput by doubling the number 
of samples. Use of internal standard performed gave the best performance both in precision of 
measurements  (RSDs for all samples were less than 4%) and ability to normalize for matrix effects 
(normalized responses ranged from 0.94-1.00). The major drawback is that an internal standard 
functions best for structurally similar molecules, potentially creating a need for new molecular 
standards when switching between substrates. The increased dilution would be desirable for its 
simplicity in implementing but would not account for any remaining variability in matrix effects. 
It also gave the worst performance in terms of measured precision (RSDs ranged from 6-9%), 
possibly due to the lowered analyte concentration associated with the higher dilution factor. 
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 Moving forward, we opted to use an internal standard, as it provided excellent preliminary 
results from the perspectives of signal normalization and variability in measurement. A 72-reaction 
screen was then performed to optimize the caffeine trifluoromethylation reaction by screening 
parameters including photocatalyst, N-oxide reagent, and co-solvent (Figure 4-11, Table 4-1). The 
triplicate analysis of all 72 reactions was performed in 380 s (1.7 s/droplet). Successful reactions 
were observed over a wide range of conditions.  Solvent choice was found to have possibly the 
largest effect on product formation. The use of 10% DMSO (6) yielded very poor turnover, while 
10% DMF and DMA (4 and 5 respectively) gave the highest turnover in general. These results 
help to illustrate both the importance of implementing methods to address matrix effects, as well 
as the successful usage of our internal standard. DMF and DMA were both seen to suppress TFM 
caffeine signal in comparison to pure acetonitrile, and as such, would most likely would not have 
been seen as viable cosolvents from our screen results without adjusting for variable ionization 
efficiencies. 
 





Figure 4-11. Condition screen for TFM caffeine reaction. (A) General reaction scheme (B) Trifluoromethyl 
caffeine MS-MS trace (m/z = 263→206, bottom) and TFM ethyl theophylline (m/z = 277→192, top) across 
72-reaction screen. Insets are enlarged regions for 125-150s (left) and molecular structures (right). (C) 
Mapped results based on the analyte to internal standard ratios. Each cell represents the average of 3 
droplets. Darker shading represents a higher observed ratio, indicating greater observed product turnover. 
 
 We then sought to validate our top 5 hits on milligram scale. Reactions were run again at 
both screen scale and 100x screen scale (3 µmol vs. 300 µmol) to show that our discovered reaction 
parameters are viable at a scale capable of yielding sufficient product formation. (Figure 4-12). 
First, we compared results obtained between the two scales using our droplet nESI-MS-MS 
method (Figure 4-12A). No major differences were observed across the two scales, showing 
conditions found to be successful on the microliter screening scale can be directly translated to 
larger milliliter scale syntheses. Also, 19F-NMR was applied as an orthogonal detection technique 
to validate our MS results (Figure 4-12B). Analysis of our 5 scaled-up reactions showed yields 
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ranging from 22-57%. The relative rankings of the reactions did not match between the original 
screen and scale-up, i.e. the best response from the screen did not give the highest product 
formation by 19F-NMR. This can potentially be accounted for by day-to-day or sample-to-sample 
variability in the reaction performance, as formation of a stable acylated N-oxide species required 
for trifluoromethyl radical formation is sensitive to the presence of water. Heterogeneity in the 
screen samples also presents a potential source of error. Even with the discrepancy in rankings, 
the employed screen appears to be capable in testing for successful reaction conditions, as all of 
its top hits demonstrated significant product formation upon scale-up. 
 
 
Figure 4-12. Validation of screen results. The top 5 reaction conditions are listed in order as conditions 1-
5 (A) Demonstration of reliability in scaling up reactions. Droplet nESI-MS comparison (n=10 droplets) of 
samples run at screen scale (3 µmol) and 100x scale (300 µmol) showed similar response for all 5 different 
reaction conditions. Normalization of results was performed within each pairing. (B) 19F-NMR analysis of 





Increasing Analysis Throughput 
 Up to this point, sample throughput was kept consistent with the initially developed method 
when MS scanning times were the limiting factor, but higher throughputs are possible by the use 
of either faster scanning instrumentation or through more targeted analysis. By using the MS-MS 
method for TFM caffeine, a duty cycle of 40 ms was accomplished. To achieve higher throughputs, 
two main components were found to be of great importance: the i.d. of the fused silica nESI emitter 
and the size of the droplets (Figure 4-13). The original conditions contained the use of 75 µm i.d. 
capillary (pulled to a 30 µm i.d. point only at the very end) for the emitter and 8 nL droplets 
(composed of 50 µM TFM caffeine in 50:50 methanol:water w/0.5% formic acid) with 12 nL PFD 
segmentation, flowed at 800 nL/min to give a throughput of 0.67 droplets/s. Increasing the flow 
rate in an attempt to increase throughput caused breakage of droplets inside of the emitter. 
Increasing the capillary i.d. to 100 µm allowed for stable flow of droplets at higher flow rates. 
Stable droplet transfer through the capillary at 1500 nL/min flow was now possible, increasing 
throughput to 1.3 droplets/s. To further increase throughput, the volumes of the droplets and PFD 
spacing were decreased to 3 nL and 4 nL respectively. By combining the reduced volume per 




Figure 4-13. Approaches to increasing throughput. Traces are for the MS-MS detection of TFM caffeine 
(m/z = 263→191). Samples were formatted into repeat 10x10 units of samples (50 µm TFM caffeine) and 
blanks (Top) The use of 75 µm i.d. capillary emitter, 8 nL droplets, and 12 nL PFD spacing was capable of 
stable analysis at 800 nL/min flow and 0.67 droplet/s throughput. (Middle) The use of 100 µm i.d. capillary 
emitter, 8 nL droplets, and 12 nL PFD spacing was capable of stable analysis at 1500 nL/min flow and 1.3 
droplet/s throughput. (Bottom) The use of 100 µm i.d. capillary emitter, 4 nL droplets, and 3 nL PFD 






 In summary, an HTE platform for the screening of visible light-driven reactions was 
developed and successfully applied to photoredox catalysis reactions. Simultaneous irradiation of 
samples in MWPs, followed by translation into segmented droplets post-reaction facilitated rapid 
reaction screening and delivery to downstream analysis. The use of nESI-MS provided detection 
of a diverse population of reaction products with minimal assay development, as well as highly 
gentle ionization for the observation of labile species. The implementation of methods to address 
variable ionization efficiency in droplet nESI-MS analysis enabled the screening across a variety 
of conditions for the trifluoromethylation of caffeine. The systems and methodologies presented 
show great promise for future work in visible light-driven reaction design and rapid diversification 
of pharmaceutical libraries to provide enhanced material and time efficiency in drug discovery.
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 Droplet Microfluidics for Screening In-Flow Photochemistry with Electrospray 
Ionization-Mass Spectrometry Analysis 
Contributor: Alexandra Sun. 
 
 Contributions of D. Steyer for this work include development of droplet handling methods 
and ESI-MS analysis methods. 
 
Introduction 
 Photoredox catalysis has exerted a significant influence on industrial chemistry by 
enabling otherwise infeasible bond disconnections and aiding sustainability efforts. Given the 
ever-increasing industrial investment, photoredox catalysis promises to be one of the most 
enabling synthetic technologies since Pd-based cross-coupling.201–204 In addition to the promise 
of reduced waste streams, the use of a more sustainable energy source (e.g. sunlight), and the 
avoidance of the hazardous and/or toxic reagents classically-employed for carbon-centered 
radical formation (e.g. AIBN, Bu3SnH, BEt3/O2), photoredox catalysis has gained meaningful 
traction due to its ability to integrate with continuous flow technology.205–207 The enhanced light 
penetration available in flow can lead to order(s) of magnitude improvements in material 
throughput, and the applicability of these combined strategies will only increase as methods for 
in-line manipulation of material continue to improve. 
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 The use of high-throughput experimentation (HTE) techniques has enabled the 
exploration of a myriad of catalysts and reaction conditions in a time and resource-efficient 
manner.69,70,72–75`  In recent years, significant efforts have been directed towards the creation of 
HTE systems for the automated processing of Pd-based cross coupling reactions on nanomole 
scale, in both batch and continuous flow settings.79,80,190,193 In comparison to conventional batch 
screening, advances in the screening of flow reactions has lagged significantly behind. While 
batch screening can be used to explore conditions for flow reactions, conditions found for 
efficient discovery-scale batch process often do not translate effectively to a pilot-scale flow 
system, and significant resources can be wasted during re-optimization.208,209 To increase 
throughput in conventional flow reaction screening, multiple reaction plugs, spaced by reaction 
solvent, need to be present in the reactor simultaneously. Taylor diffusion of these plugs into 
surrounding carrier solvent makes the determination of exact reaction conditions impossible and 
leads to cross contamination over longer incubation times. Nevertheless, strides towards the 
development of such systems have been made, affording the mass spectrometry (MS) analysis of 
flow reactions every 45 s, though the reactions performed were limited to a 3-min incubation 
time.210 By using Argon gas as an inert driver of flow, a system for screening photoredox reaction 
plugs in flow with extended incubation times has been established, though only a single 15 µL 
reaction can be run at a time.211–213 As it stands, there is a need for systems that can increase 
throughput for screening flow reactions. 
 Droplet microfluidics presents excellent features for screening photochemical flow 
chemistries. Segmentation of samples with an immiscible phase can enable the simultaneous 
handling of numerous samples over extended periods of time.10 Droplet samples are also well 
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suited for photocatalytic reactions, as the micrometer dimension of the reaction vessel allows for 
high photon flux through the reaction channel in an analogous manner to the narrow tubing 
employed in flow reactors.214–217 Droplet samples in closed systems also have the benefit of 
avoiding solvent evaporation, allowing for the use of volatile solvents over extended incubation 
times. Use of droplet microfluidics promises to propel forward in-flow screening efforts to where 
throughputs can approach or even match the throughput of batch-scale screens, while more 
accurately portraying conditions for flow reactions. 
 In this work, droplet samples were applied as reactors for photoredox catalysis reactions. 
Three approaches to analyzing reactions in droplets by ESI-MS were examined, with the use of 
a sheath sprayer being selected for further work. Observation of photoredox catalysis 
trifluoromethylation reactions performed in 4 nL droplets, formed in perfluoroalkoxyalkane 
(PFA) tubing, demonstrated the feasibility of running photoredox catalysis reactions in droplet 
format. For reactions in flow, a photoredox catalysis Smiles-Truce rearrangement was used. By 
loading 4 nL reaction droplets into PFA tubing, in-flow reactions were performed over an hour 
by use of oscillatory flow patterns. Finally, a microfluidic system for adding reaction components 
to individual substrate-containing droplets was developed. This led to the creation of an all-
droplet, in-flow photoreactor, where reagent addition is performed, followed by flow through a 






 Perfluorodecalin (PFD) and trichloro(1H,1H,2H,2H-perfluorooctyl)silane were purchased 
from Oakwood Products (Estill, SC). All other reagents were purchased from Fisher Scientific or 
Sigma Aldrich. 
Reagent Preparation for Fluoroalkylation Reactions 
            1 mol% photocatalyst and 4 equivalents N-oxide reagent were dissolved in acetonitrile. 
The reagent solutions were sparged with a stream of nitrogen gas for 5 min. 4.4 equivalents of 
acetic anhydride reagent were subsequently added, and the mixtures were stirred for 10 min to 
facilitate complete conversion to the acylated species. Separate solutions of substrate in acetonitrile 
(0.1 M) were also prepared. 10 µL of each solution were mixed together in a PCR tube to form the 
final reaction mixture. 
 
Reagent Preparation for Smiles-Truce Rearrangement Reactions 
 To a flame dried 1-dram vial, equipped with a Teflon coated oval shaped stir bar, was 
added tetrabutylammonium benzoate (30 mol%), and Ir(dF(CF3)ppy)2(5,5’d(CF3)bpy)PF6 
photocatalyst (1 mol%). The vial contents were then dissolved in anhydrous acetonitrile (3 mL). 
Finally, anethole was added (1.2 equiv). This solution was sparged under argon for 15 min. 
Separate solutions of substrate in acetonitrile (0.1 M) were also prepared. For reactions formed 
directly from well-plates, 10 µL of each solution were mixed together in a PCR tube to form the 
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final reaction mixture. For all-droplet chemistry, droplets were formed from substrate solution, 
and had reagents added on-chip. 
Droplet Generation 
 Droplet generation from microwell plates (MWPs) was performed using equipment and 
methods described in our previous work. Briefly, samples were drawn into either 100 µm inner 
diameter (i.d) x 360 µm outer diameter (o.d) perfluoroalkoxyalkane (PFA) tubing (IDEX Health 
and Science, Oak Harbor, WA) by a PHD 2000 Programmable syringe pump (Harvard Apparatus, 
Holliston, TX). 6 µL samples were deposited into 384 PCR MWPs (Corning, Corning, NY) with 
PFD placed on top. While solution was being withdrawn through the tubing, an XYZ-position 
manipulator moved the tubing between sample wells and fluorous phase to form alternating 
droplet/carrier phase trains.  
 
Photoreaction Chamber Assembly 
 All reactions were run in a photoreaction chamber made in-house. A 150 mm wide x 15 
mm deep polystyrene petri dish was lined with aluminum foil to promote internal reflection of 
light. A 4.4 W blue LED strip (Creative Lighting Solutions, Columbia Station, OH) was placed 
around the edge of the interior of the dish. A small slit was cut from the petri dish wall to run wires 
and tubing through. During reaction, tubing was coiled in the middle of the dish, only approaching 




Sheath Spray and MS Setup 
 Tubing containing droplets was threaded through sheath sprayer (Agilent Technologies, 
Santa Clara, CA) until approximately 0.5 mm was protruding. Sheath and droplet flows were 
driven by Fusion 400 syringe pumps (Chemyx, Stafford, TX). ESI-MS analysis was performed on 
an Agilent 6410 triple quadrupole mass spectrometer (Agilent Technologies, Santa Clara, CA). 
ESI potential was set to 2500 V, nebulizer gas to 15 psi, and drying gas from MS source was 10 
L/min at 325 ºC. Mass spectrometer was set to scan from 75 to 750 m/z at 73 ms per scan. 
Experiment using nESI-MS (Figure 5-1A) followed procedures from chapter 4. Briefly droplets 
were flowed from PFA tubing to a nESI emitter by use of a PicoclearTM union (New Objective, 
Woburn, MA). Applied nESI potential was 1.75 kV. Mass spectrometry analysis was performed 
on a Micromass Quattro Ultima triple-quadrupole mass spectrometer (Waters, Milford, MA). 
 
Chip Fabrication 
 Microfluidic chips were fabricated using standard soft lithography procedures.125 SU-8 
2050 photoresist was spun to 100 µm depth on silicon wafers (University Wafer, Boston, MA) 
then developed using photolithography to form negative masters. Uncured polydimethylsiloxane 
(PDMS) (Curbell Plastics, Livonia, MI) was poured on top of clean masters or blank wafers and 
allowed to cure for 1 h at 65 °C. Patterned PDMS and blank PDMS were baked for 1 h at 150 °C, 
followed by 1 min of exposure to atmospheric plasma and baking for 2 h at 150 °C to create an 
irreversible bond. Chip channel surfaces were treated with 2% trichloro(1H,1H,2H,2H-
perfluorooctyl)silane in PFD by flowing 10 internal volumes through over 10 minutes, followed 
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by 2 hours baking at 65 ºC. Chips were soaked in acetonitrile overnight to prevent solvent loss 
from droplets. 
 
Reagent Addition Chip Setup 
 PDMS devices were 100 µm depth. Droplets flowed in from a 100 µm wide channel that 
expanded to 200 µm wide at the point of intersection with reagent addition channel, which was 
100 µm wide at this point. The final device was 200 µm wide at all openings to accommodate 
direct insertion 360 µm o.d. tubings. Channels were wetted with PFD to help ease insertion of 
tubing. 
Results and Discussion 
Analysis of Reaction Droplets 
 To analyze the contents of droplets post-irradiation, three separate approaches were 
explored. Since synthetic reactions are typically highly concentrated with reagents often present 
at > 10mM, our approaches for ESI-MS analysis aimed to lower this concentration down before 
analysis avoid saturation of MS signal. First, the nESI-MS method from chapter 4 was used on 25 
mM trifluoromethylated N-Boc-5-bromo-7-azaindole (azaindole) dissolved in reaction mixture 
and diluted 50:1 only with acetonitrile, the original reaction solvent. Stable detection of 
trifluoromethylated azaindole from these samples was easily achieved without saturating the 
observed MS signal (Figure 5-1A). This result suggested that droplet formation and nESI-MS 
analysis can be performed without the need for the dilution solvent from chapter 4 (50:50 
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methanol:water w/0.5% formic acid); however, this approach would only be compatible with 
reactions that can be run at lower (< 1 mM) concentrations. 
 The second method investigated was the in-line dilution of droplet samples into a 
continuous stream. Droplet samples, composed of undiluted 25 mM trifluoromethylated azaindole, 
flowed at 200 nL/min into a stainless-steel tee containing 100 µm i.d. channels. The continuous 
stream was composed of the 50:50 methanol:water w/0.5% formic acid and flowed at 100 µL/min, 
giving a nominal 500x dilution before ESI-MS analysis. Lines in and out of the tee were 100 µm 
i.d. PFA tubing. Each individual droplet was observable in the azaindole MS trace at 7 
droplets/min, though restrictions on greater throughputs were seen based on widening of sample 




Figure 5-1. nESI-MS and tee-dilution ESI-MS systems to perform the analysis of in-droplet chemistries. 
(A) Trace for trifluoromethyl azaindole (m/z = 365) using nESI-MS system and acetonitrile-only dilution 
(B) Schematic of in-line dilution of droplets into continuous stream. (C) Trace for trifluoromethyl azaindole 
fragment (m/z = 309) using in-line dilution. 
 
 To remove the restrictions in throughput caused by widening of sample bands after dilution 
while keeping reaction concentrations high, a sheath sprayer was employed (Figure 5-2A,B). 
Droplets samples emerging from PFA tubing merge into a continuously spraying sheath flow and 
immediately to ESI-MS analysis. Operation of this system has been shown for analyzing 
enzymatic reactions at throughputs exceeding 1 droplet/s.43 For the analysis of droplet photoredox 
reactions, the sheath flow was kept high (100 µL/min) and droplet flow low (0.5-1.0 µL/min) to 
dilute the droplets (nominally 100-200x) during the electrospray process. 
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System for In-Droplet Photoredox Chemistry 
 For performing in-droplet photochemistry, an easily assembled photoreactor for irradiating 
droplets was created by covering a petri dish with aluminum foil (Figure 5-2C). A strip of blue 
LED lights was lined around the dish and the tubing coiled in the middle to promote uniform 
irradiation across the contained samples. A small hole was cut out of the reactor wall to allow for 
the LED power cord and droplet tubing to enter. 
 
Figure 5-2. Setup for irradiation and ESI-MS analysis of droplet samples. (A) Setup of sheath sprayer. (B) 
Schematic of sheath sprayer for droplet work. Tubing with droplets runs through the middle of the sprayer. 
Sheath liquid flows directly around tubing (Blue arrow). Electrospray is aided by use of nebulizer gas 
(Black arrow) (C) Photoreactor setup. To react droplets in tubing, a petri dish was coated with aluminum 
foil, with an LED array lining the rim. 
 
 To demonstrate the general operation of our system, the analysis of in-droplet photoredox 
catalysis trifluoromethylation reactions was performed (Figure 5-3). 4 separate substrates were 
chosen. 3 were hits from the compound library screen from previous work (Figure 4-4, 4-5) 
denoted as PF1, PF14, and PF15. The fourth was azaindole, one of the original substrates from the 
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development of the photoredox catalysis trifluoromethylation reaction.205 4 nL droplets containing 
equal parts 100 mM substrate solution and trifluoromethylation reaction solution, segmented by 8 
nL PFD, were generated into 100 µm i.d. PFA tubing and irradiated for 10 minutes. Each droplet 
contained only one of the 4 substrates, which were cycled through every 4 droplets. After 
irradiation, droplets were flowed at 500 nL/min to the sheath sprayer. 50:50 methanol:water w/ 
0.5% formic acid sheath liquid was flowed at 100 µL/min. ESI-MS analysis of droplet samples 
was performed at 17 droplets/s. By extracting out the expected m/z values for the 
trifluoromethylated products, the formation of product from each individual reaction could be 
monitored. As expected, every 4th droplet in each trace demonstrated high signal for the product 
of interest, as well as high product signal rotating through the 4 traces in the expected ABCD 
pattern. This result not only shows that the in-droplet reactions were successful, but that the 




Figure 5-3. Analysis of in-droplet trifluoromethylation reactions (Left) Extracted m/z ratios for 
trifluoromethylated products. For all substrates but azaindole, intact MH+ molecular ions were monitored. 
For azaindole the previously observed fragment ion (m/z=309, Figure 4-1) was monitored. (Right) 
Structures of substrates associated with the MS traces directly to their left. 
 
 Also explored was the effect of running reactions in 4 nL droplets in place of a more 
standard screen scale at 20 µL (Figure 5-4A,B). For the 20 µL reactions, the PCR tubes were 
placed directly in the middle of the photoreactor for the 10 minutes of irradiation. After reaction, 
the solutions were then formed into 4 nL droplets for direct comparison to the two volume scales. 
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The quotient of the product signal over the summed product and substrate signals (
𝑃
𝑃+𝑆
) was used 
to appraise reaction progress. For the two substrates that performed the best in the 20 µL reactions 
(PF1 and azaindole), only slight increases in product formation were observed when run in droplet 
format; however, the increase was drastic for the lower performing substrates (PF14 and PF15) 
(Figure 5-4B,C). The changes in reaction performance can be attributed to the narrower sample 
geometry. The 100 µm i.d. tubing presents a drastically narrower pathlength, lowering the amount 
of light absorbed and possibly promoting more uniform irradiation across the entire sample. Such 
an effect could be helpful in promoting the observation of product in poorly performing reactions, 
or in reducing reaction time requirements in screening for both flow reaction and batch reaction 
screening. 
 
Figure 5-4. Comparison of reactions performed at standard screen scale and droplet scale (A) General 
schemes for running reactions at different scales (Left) Reactions run at 20 µL were irradiated immediately 
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after mixing in PCR tubes and then reformatted into 4 nL droplets for analysis (Right) For in-droplet 
reactions, premixed solution was reformatted into 4 nL droplets, which were then irradiated. (B) Evaluation 
of performance across 4 substrates in either 20 µL or 4 nL volume. In every case, P/(P+S) response was 
found to be similar or significantly higher in droplet format. N=20 droplets for each reaction. (C) Example 
spectra from both 20 µL (Top) or 4 nL (Bottom) volume PF15 reactions. The yellow arrow indicates 
substrate m/z value, while the red arrow indicates product m/z value. In the 20 µL reaction, the substrate 
response was over double that of the product; however, the product response was even greater than that of 
the substrate in the 4 nL reaction. 
 
Oscillating Flow Reactor 
 With the demonstrated results for in-droplet reactions, we moved to explore droplet-based 
flow reactions. As shown in Figure 5-3, droplet samples were not subject to diffusion of analytes 
into the carrier phase, giving the ability to react numerous samples within the same system for 
extended periods of time. For this flow chemistry work, a photoredox catalysis Smiles-Truce 
rearrangement was used as a model system (Figure 5-5). 
 




 To allow for extended reactions in-flow inside of our PFA tubing, an oscillatory flow 
scheme was employed (Figure 5-6A). Droplets were formed from substrate and reaction mixture 
into a 100 µm i.d. PFA tube, with droplet contents alternating between containing the N-((3,4-
difluorophenyl)sulfonyl)acetamide substrate (Figure 5-5, Top left) and the N-((4-
cyanophenyl)sulfonyl)acetamide (Figure 5-5, Bottom left) substrate, denoted as 3,4 F and 4 CN 
substrates respectively. A PCR tube had a 400 µm hole drilled in the cap and was filled with PFD. 
The outlet of the tubing was threaded through the hole and submerged in PFD to avoid evaporation 
of samples inside of the tubing. Upon irradiation, the droplets were flowed at 200 nL/min, first 
withdrawing towards the syringe pump for 10 min, followed by 10 min of infusing away from 
syringe. This process was performed 3 times, allowing for 1 hour of continuous flow reaction. 
Upon analysis under the same conditions as the previous experiments, both reactions were 
observable in alternating fashion by monitoring the product m/z traces. Measured turnover for both 
reactions was found to be significant by 
𝑃
𝑃+𝑆
, with values of 0.919 ± 0.022 for the 4 CN substrate 
and 0.499 ± 0.044 for the 3,4 F substrate in the droplet samples shown in Figure 5-6B (substrate 
traces not shown). There was observed variability in the product response for droplets of the same 
content (RSD in product response was 16% for both populations), which may indicate variable 
performance of the sheath sprayer. Further improvement to setup procedures and ESI parameters 
could help to lower this variability. The current setup accommodated 40 droplets for flow reaction 
and could conceivably increase to >100 droplets with longer tubing lengths and shorter oscillation 
periods. As currently demonstrated systems for oscillating flow in a reactor have been limited to a 





Figure 5-6. Reaction of droplets in oscillating flow. (A) Scheme for oscillating flow reactor. While being 
irradiated, droplet flow was cycled between moving towards (withdraw) or away from (infuse) the syringe 
to allow for continuous flow in a linear, volume limited reactor. (B) Extracted traces for 4 CN (m/z = 309) 
and 3,4 F (m/z = 320) substrate reaction products, showing the formation of the two products in alternating 
droplets. 
 
Reagent Addition and Online Screening System 
 While reactions up to this point are occurring at the low nL scale, the true usage of reagent 
is the amount that is deposited in the MWP before droplet generation. To create a system where 
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the consumption of valuable reagents is approaches the volume found in the droplets, a 
microfluidic reagent addition device was employed (Figure 5-7). PDMS chips were fabricated in 
which individual droplets could be imported from 100 µm i.d. PFA tubing, flowed through an 
addition region to receive reagents, and then be exported to 150 µm i.d. PFA tubing for irradiation 
and ESI-MS analysis. Larger 150 µm i.d. tubing was used for the droplets post-addition as the 
larger volume droplets were sometimes unstable in the 100 µm i.d. tubing. Consistent addition of 
reagent to 4 nL acetonitrile droplets was achieved with the employed geometry (Figure 5-7C). By 
keeping droplet flow consistent (800 nL/min), the amount of reagent added to each droplet was 
controllable by the flow of the reagent stream. The reagent solution for the trifluoromethylation 
reaction was utilized in the demonstration of the reagent addition device, as it showed a deep 
yellow color. At 100 nL/min reagent flow, the final droplets were composed of 33 ± 2% added 
reagent, while a 200 nL/min reagent flow created droplets with 45 ± 4% added reagent, showing 
consistent addition to droplets at both flow rates. Also tested was for this geometry was the carry-
over between droplets. To test for this, droplets were made in 10x10 units, alternating between 
being composed of either pure acetonitrile or trifluoromethylation reagent solution, and pure 
acetonitrile used as the addition stream. As the reagent addition stream is now colorless, any 
material carry-over from trifluoromethylation reagent droplets into the addition stream will lead 
to a yellow hue in the proceeding droplets. From this approach, pure acetonitrile droplets following 
trifluoromethylation reagent droplets had no observable yellow coloration, showing that this 




Figure 5-7. Reagent addition device operation. Samples used were either pure acetonitrile (clear, colorless) 
or trifluoromethylation reagent solution (dark yellow). Droplets were 4 nL initially, with 12 nL PFD 
spacing. (A) Device in operation. Each incoming droplet from the left received solution from the upper 
channel and moved right to export. Additional channels on top and bottom of channel were placed for 
optional saltwater electrodes. This feature was not necessary, as droplets coalesced with reagent stream 
without application of electric field. (B) Final design of reagent addition device, with electrodes removed. 
(C) Droplets post addition in PFA tubing. Droplet flow in was 800 nL/min, while reagent addition flow was 
200 nL/min. Output droplets were found to contain 45 ± 4% added reagent. (D) Carry-over evaluation. 
Droplets were generated from either pure acetonitrile or reagent mixture. Pure acetonitrile was added to 
each droplet. Pure acetonitrile droplets (highlighted by blue boxes) flowed through addition device after 
reagent droplets show no coloration, indicating that very low carry-over exists during the operation of the 
reagent addition device. (E) Droplets at 6% reagent, showing significantly more yellow coloration than the 
blank droplets in (D). 
 
 This reagent addition device was then implemented as part of an online flow reactor system 
(Figure 5-8). In this system, substrate-containing droplets are generated from MWPs, then 
connected to the reagent addition device. For reactions not requiring external input like light or 
heat, this would constitute the start of the reaction. We aimed to perform photoredox catalysis, so 
droplets leaving the reagent addition device were then flowed into the photoreactor shown in 
119 
 
Figure 5-2. After flowing through the photoreactor, droplets then were sent directly to ESI-MS 
analysis.  
 
Figure 5-8. Complete system for in-droplet flow reaction screening. (A) Syringe pump driving both droplet 
flow and reagent flow into reagent addition chip. Syringes were 100 µL and 25 µL respectively, giving the 
desired 4:1 flow ratio. Multichannel syringe pumps or an additional pump can be used when ratios do not 
match perfectly with syringe sizes. (B) Syringe pump driving sheath flow. (C, in blue box) Reagent addition 
device. (D) Photoreactor chamber (E) Sheath sprayer for ESI-MS analysis. 
 
 Finally, the above system was applied to the Smiles-Truce rearrangement used in the 
previous section. 4 nL acetonitrile droplets containing the 4 CN substrate with 12 nL PFD 
segmentation were flowed through the reagent addition device at 800 nL/min, with 200 nL/min 
reagent flow, creating 7 nL full reaction droplets for irradiation and analysis. Irradiation time was 
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approximately 7 min, calculated from the volume of the tubing contained within the reactor and 
the 1000 nL/min volumetric flow rate. Analysis of droplets post-irradiation at 20 droplets/min not 
only showed that product had formed, but that the formation was highly consistent across all of 
the droplet samples (Figure 5-9). To confirm that signal was caused by in-droplet chemistry, 
premixed reaction mixture was made into droplets and analyzed in the same manner as the previous 
sections. Very little signal was observed, with the droplet samples barely distinguishable from 
background noise. These results indicate the successful application of our system for performing 
and analyzing in-droplet light-mediated chemistry.  
 
Figure 5-9. Results from online flow reactor and control experiments. Traces represent the m/z of the 
Smiles-Truce rearrangement product for the 4 CN substrate (m/z = 309). (A) Droplet samples processed 
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with online flow reactor. (B) Control samples for (A), where no irradiation was applied. Very little signal 
was observed, indicating that results from (A) are the result of in-droplet chemistry. 
 
 The application of this inclusive screening setup provides significant advantages for 
screening work. First, MWPs are a format amenable for creating large libraries of conditions or 
substrates for screening work. By making droplets from MWPs, we can explore a wide variety of 
conditions with great ease. Also, the low nL volumes consumed allow for reaction 
condition/substrate libraries to be reused numerous times. Reagent addition allows for these 
libraries to remain intact by adding reaction components directly to droplets in place of into the 
wells, while minimizing the usage of reaction components. By applying incubation and analysis 
of droplets directly after reagent addition, the downstream incubation and analysis was condensed 
into one simplified system. 
 
Conclusions 
 Droplet microfluidic approaches to screening light-mediated reactions were successfully 
demonstrated. The application of ESI-MS provided a highly versatile analytical approach for 
monitoring reaction turnover. The use of droplet microfluidics presented several significant 
advantages for reaction screening, for both batch scale and flow reactions. First, acceleration of 
photoredox catalysis reactions was observed in droplet samples, which can potentially decrease 
required incubation times or promote the observation of poorly performing reactions. Second, the 
simultaneous reaction of droplets in oscillatory flow patterns allows for the extended incubation 
of numerous samples in a flow reactor. Finally, the use of reagent addition and the application to 
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a continuous flow reaction system with in-line ESI-MS analysis allowed for the rapid screening of 
flow reactions with minimal reagent usage. As a whole, the described approaches contain major 
advantages over state-of-the-art systems for screening flow reactions. 
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 Future Directions 
 Described within this thesis was the development of a platform for the nanoelectrospray 
ionization-mass spectrometry (nESI-MS) analysis of droplet samples for applications in biological 
and organic synthetic studies, as well as the use of droplet microfluidics and ESI-MS for screening 
flow chemistry reactions. The nESI-MS platform has promise not just on the basis of the robust, 
label-free analysis that it can apply, but also in the developed approaches for providing impressive 
control of nL/min flow rates. Potential applications could include on-chip cell and tissue 
monitoring, drug discovery, and rapid clinical diagnostics. One area of particular interest is in the 
design of new proteins catalysts for industrial applications. For the application to in vivo 
neurochemistry, improvements could be made to the nESI-MS method to allow for greater 
coverage and sensitivity. The nESI-MS assay could also be paired with in vivo microdialysis to 
provide high temporal measures on a conventional sampling method. For the work interfacing 
organic synthetic chemistry with MS analysis, improvement to these systems could be made by 
creating a continuous system for generating droplets and flowing to further operations, which 
would remove the need for repetitive formation of manual connections. Finally, presented is a 
proposed design for combining reagent addition, flow incubation and ESI-MS analysis into one 
chip for screening flow reactions.
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nESI-MS: Protein Engineering 
 Enzymes have been of significant interest in recent years not just as regulators of biological 
systems, but as catalysts to aid traditional organic synthetic workflows.218,219 The use of enzymes 
for molecular synthesis can present some impressive features, such as mild reaction conditions, 
high regio- and enantio- selectivities, and access to otherwise difficult transformations. In many 
cases the protein needs to be reengineered to accept the substrate in place of its native substrate. 
In the engineering of new proteins, the process of directed evolution is often applied, where over 
rounds of mutation and selection, proteins are created with enzymatic activity towards the desired 
substrate(s). 
 Droplet microfluidics presents a powerful platform for performing directed evolution of 
proteins.88,220 Within a round of evolution, the amount of information acquired about the protein’s 
sequence space and its effect on catalysis goes up as more samples are run. By assaying massive 
amounts of mutants in short time frames, droplet microfluidics allow for tremendous gains in the 
acquired information to be achieved. Current efforts in the Kennedy Lab, in collaboration with 
scientists at Merck & Co., have been towards the development of a droplet microfluidics platform, 
with MS analysis, for the directed evolution of enzymes.43 Within these efforts, a microfluidic 
device for the splitting of enzyme-containing droplets post-incubation is employed, sending one 
portion to ESI-MS analysis and the other to a sorting region. The signal from the mass spectrometer 
is then used to determine which droplets contained elevated levels of product, and initiates sorting 
of droplets into “winners” and “losers”. Downstream analysis of the winner droplets would then 
determine which mutations in the protein’s sequence promoted the transformation of interest. 
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 The nESI-MS platform described in chapter 2 presents an excellent alternative to standard 
ESI-MS for chemical analysis in directed evolution applications. It has already shown the ability 
to monitor in-droplet enzymatic turnover and perform robust analysis of over 10,000 droplets. 
With an achievable throughput of at least 10 droplets/s, 280,000 samples could be analyzed in an 
8-hour period. It also is compatible with smaller droplet samples, which would reduce reagent 
usage. The current ESI-MS method incorporates 50 nL droplets,43 which are 800x larger than the 
smallest (65 pL) demonstrated by the nESI-MS system. Possibly of most importance is the 
tolerance of nESI-MS to biological matrices, which would aid in the detection of enzymatic 
product when turnover is low. Sensitive detection of product formation could be critical in earlier 
rounds of evolution when catalytic activity is often very poor. 
 
Improvements to nESI-MS Neurochemical Detection 
 The results demonstrated in chapter 3 showed the potential of nESI-MS to analyze droplet 
samples made from in vivo sampling experiments. An immediate way to improve upon this work 
is to increase analyte coverage in order to provide greater information about neurochemical 
dynamics in the probed brain region. To increase the coverage, detection limits for the method, 
limits of detection (LODs) need to be improved. Many neurochemicals of interest for in vivo 
sampling experiments, like dopamine and serotonin, often will exist at concentrations near or even 
below 1 nM in the collected samples.87,221 The LODs achieved for the nESI-MS method ranged 
from 2-90 nM, meaning that if other analytes of interest perform similarly, a significant portion 
will not be detectable. 
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 In a MS assay, detection limits are dependent on the ability of our system to create gas 
phase analyte ions and transmit them to the detector, and on the inherent backgrounds in the 
measurement. Improving analyte detection starts by improving the formation of gas phase ions 
during the nESI process. Further reductions in emitter i.d and applied flow rate could bolster matrix 
tolerance while simultaneously providing additional time to analyze droplet samples. Also, 
changes in sample matrix, like pH modifiers to promote the protonated species, organic solvents 
to hasten desolvation of nebulized droplets, and increased dilution factor to reduce matrix effects 
could all aid in the formation of gaseous analyte ions. 
 The use of newer instrumentation also promises to aid in neurochemical detection. The 
mass spectrometer used in the original studies was over 20 years old, and while capable of 
meaningful work, does not represent how newer instrumentation may perform.  Employing newer 
instrumentation with improved ion optics to promote analyte transmittance through the mass 
spectrometer, quieter electronics to reduce electronic backgrounds, and higher mass resolution to 
help reduce chemical backgrounds would all aid in the detection of lower concentration 
neurochemicals. An additional benefit to newer generations of mass spectrometers is the enhanced 
scan rates. The work in chapter 2 showed that reducing MS-MS dwell times to below 15 ms caused 
large increases in signal variability, while new generation mass spectrometers boast dwell times 
as short as 1 ms. This increase in scanning speed could be applied towards monitoring more 
neurochemicals simultaneously or towards attaining more scans per analyte. With some or all of 





Pairing Droplet nESI-MS Assay with In Vivo Microdialysis 
 The use of microdialysis for in vivo sampling experiments is a widespread practice and a 
great application for the droplet nESI-MS method. Application of nESI-MS analysis with droplet 
segmentation would allow for higher temporal resolution and/or higher chemical coverage than 
previously demonstrated schemes for monitoring neurochemicals from dialysate. A major hurdle 
for combining microdialysis with nESI-MS is the mismatch of flow rates. The sample stream, 
internal standard, and segmentation phase coming together to form droplets would combine to give 
flow rates well over 1 µL/min. For our nESI-MS method to be applicable, flow rate to the emitter 
should be below 200 nL/min. 
 While work will be required to account for this flow mismatch, the excess flow may 
actually prove to be beneficial in the end. Shown in figure 6-2 is a proposed system for generating 
droplets and splitting flow that would not only allow for nESI-MS monitoring of dialysate droplets, 
but the simultaneous collection of dialysate for more conventional analysis. In this setup, droplets 
are formed from dialysate with simultaneous addition of internal standard. The droplets are then 
asymmetrically split, such that the majority of dialysate moves toward collection. As only a small 
amount of the dialysate (i.e. <10%) is needed for nESI-MS analysis, collection rate of dialysate is 
not significantly affected. The addition of internal standard (and carrier phase) is before the split 
in the proposed design. In this case, fluctuations in the flow at the split would not affect the ratio 
of analyte/internal standard concentrations observed in the formed samples, but the split in flow 




Figure 6-1. Proposed design for pairing microdialysis and droplet nESI-MS analysis with simultaneous 
collection of dialysate for further analysis. 
 
 
 The setup in Figure 6-1 could provide utility in a few different ways. The droplet nESI-MS 
method would provide heightened temporal information over larger fraction collection, giving 
further insight into the dynamics of targeted neurochemicals. nESI-MS analysis may also provide 
access to neurochemicals that are not covered in whatever analytical methodology that is applied 
to the bulk collected sample, as the most commonly applied methods require analytes to have 
electrochemical activity or reactivity with a derivatizing agent. In the opposite direction, the 
chemical coverage of a direct nESI-MS method may never match what can be achieved in 
separation-based analyses, making a stand-alone droplet nESI-MS method potentially less 




Online Droplet Formation from Well Plates 
 The work in chapters 4 and 5 revolved around the generation of droplet samples from 
microwell plates (MWPs). A drawback to the applied approach is that droplet generation and 
downstream manipulations are performed on separate setups. To simplify this process and give a 
wider general appeal, the formation of a system to continuously form droplets and transfer to 
downstream operations should to created. The use of a peristaltic pump presents a simple method 
for achieving both droplet generation from MWPs and flow to downstream operations. Peristaltic 
pumps function by the use of rollers to compress the contained tubing. By driving the roller across 
the tubing, the solution from the outlet is draw in, while the solution in front is forced forward. 
Potential issues could arise from breakage of the droplets upon compression of the tubing, 
observed pulsing of flow as the rollers cycle, as well as restrictions in the materials and sizes of 
tubing available. Another option would be to apply high gas pressure to the droplet generation 
region or low pressure around the mass spectrometer source to drive flow. Both approaches would 
require the area of interest to be sealed to the point of being gas tight, which could be a significant 
engineering task and possibly difficult to maintain and operate. 
 An option that would allow for the current use of syringe driven flow to remain in place is 
the use of microfluidic valves. By the application of mechanical pressure, polydimethylsiloxane 
(PDMS) channels can be closed to flow. This could be leveraged to make a microfluidic device 
that allows for generation of droplets off a MWP through one channel while simultaneously 
flowing droplets out through another. A schematic for general operation is shown in Figure 6-2. 
In this proposed device, there are two halves that can both generate and infuse droplets. Flow in 
both halves is operated by syringe pumps containing dual infusion/withdrawal capabilities. During 
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operation, one half of the device would be forming droplets from a MWP. The valve leading to 
the device outlet would be closed, stopping the withdrawal of solution from the outlet region. The 
other half of the device would be infusing previously formed droplets. The valve to its inlet would 
be closed to prevent flow in that direction. At the end of a cycle, the two halves would switch 
operation, allowing for continuous infusion of droplets to further operations. 
  
 





 In this device, throughput would be limited to the slower of two operations. With 150 µm 
i.d. tubing, we have found that droplets as small as 2 nL with 4 nL PFD spacing can be formed 
from MWPs at frequencies up to 1.3 droplets/s. For methods requiring lower flow rates, 
frequencies would be limited by the export rate. For example, nESI-MS analysis at 200 nL/min 
would yield a throughput of 1 droplet every 2 s for 2 nL droplets with 4 nL spacing. This 
throughput would still be a huge increase over commercial nESI systems, which top out at about 
2 samples/min.120 Export of droplets from this system at higher flow rates, like used in chapters 4 
and 5, would allow for the system to operate closer to the droplet generation rate limit. 
 
Microfluidic Chip for Screening Flow Reactions 
 Chapter 5 outlined how droplet microfluidics could be employed to improve throughput 
and material consumption in screening flow reactions. To move this forward, we would like to 
integrate all of the desired functions into a single microfluidic chip (Figure 6-3). So far, the 
introduction of intact droplets to a microfluidic device for performing reagent addition has been 
accomplished. Extending the channel post-addition would allow for incubation to be easily 
performed without need for export of droplets from the chip. Performing on-chip dilution and ESI-





Figure 6-3. Overview of inclusive device for screening droplet flow reactions with ESI-MS analysis. 
 
 As shown in chapter 5, broadening of sample bands can limit throughput when flowing 
droplets into a continuous stream. A large deal of this may be associated with the use of multiple 
connections (dilution device to tubing, tubing to ESI source) and the volume that exists post 
dilution. By simplifying the system, we were able to narrow the analyzed bands post-dilution 
(Figure 6-4A,B). A 100 µm i.d. fused silica emitter was directly inserted into the metal tee, 
reducing both the number of connections and volume post-dilution (Figure 6-4A). Resolution of 6 
nL droplets, flowed at 500 nL/min into a 100 µL/min dilution stream (50:50 methanol:water 
solution w/0.5% formic acid) was now observed at 15 droplets/min in the detection of 
trifluoromethyl azaindole (Figure 6-4B), which was a marked increase over the 7 droplets/min 
shown in chapter 5. However, sputtering and inconsistent Taylor cone formation at the emitter tip 
were observed. Standard ESI sources contain heated gas flows to aid in nebulization and 
desolvation of the sample stream and provide consistent spray, which was not present for this 
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experiment. While ESI and nESI emitters are routinely integrated into microfluidic chips, no 
designs have been demonstrated with such high flow rates in mind (~100 µL/min). A proposed 
design for performing ESI-MS of a high-flow dilution stream on-chip is shown in Figure 6-5C. 
Electrospray of sample occurring at the outlet of this design would be aided by parallel nitrogen 
streams. Heating of these streams before entering the chip could be performed to give further 
control over the performed electrospray. Treatment of the chip surface near the ESI outlet with 
fluorous derivatization agent could aid Taylor cone formation by helping to contain sample stream 
near the outlet.  Successful development of this microfluidic ESI emitter would enable the creation 
of device in which all of the major components for flow reaction screening with ESI-MS analysis 
(reagent addition, incubation, dilution, electrospray) are included. 
 
Figure 6-4. (A) Setup for dilution of droplets with direct transfer of dilution stream into an electrospray 
emitter. (B) Trace for trifluoromethyl azaindole (m/z=309) for droplets run with setup in (A). (C) Schematic 
for on-chip electrospray of high flow rate sample streams. Dilution stream flows down the middle and 
sprays upon emergence from chip (right side). Nitrogen streams are flowed parallel and emerge surrounding 
the sample stream to aid in electrospray. Grey circles represent inlets for nitrogen streams. 
 
 Finally, the implementation of different substrates for device fabrication could be explored. 
The use of PDMS enables rapid prototyping of device geometries for exploring microfluidic 
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operations, but devices can significantly swell in the presence of different organic solvents. 
Swapping out PDMS for other substrates in the explored designs, such as glass or thermomoldable 
polymers, would allow for the fabrication of more widely applicable devices. 
 
Conclusions 
 Significant challenges associated with the MS analysis of microfluidic droplets were 
approached by the development of a droplet microfluidic nESI-MS platform. This platform not 
only demonstrated robust MS analysis of 10,000’s of droplet samples, but also was capable of 
performing sensitive analysis of  biological sample droplets as small as 65 pL. Combining 
microfabricated push-pull probes, droplet microfluidics, and nESI-MS analysis provided 
unprecedented spatiotemporal resolution for an in vivo sampling method with the chemical 
coverage provided by MS. The application of droplet-based nESI-MS to organic synthesis, 
specifically photoredox catalysis, created a HTS platform that included gentle ionization for 
observing labile molecules, with a throughput as high as 3 droplets/s attained. Finally, the use of 
droplet microfluidics increased throughput in the MS-based screening of flow reactions to 20 
samples/min, as well as enabling for extended in-flow incubation. Future work includes 
implementing the nESI-MS droplet microfluidic platform for protein engineering, improving the 
neurochemical coverage of the nESI-MS assay, implementing nESI-MS to microdialysis 
sampling, creating a continuous system for droplet generation off of MWPs, and the creation of an 
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